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SUMMARY 
 
Genomic DNA is not freely accessible but it is compacted into chromatin by 
wrapping DNA around a histone octamer. Basic unit of chromatin is a nucleosome. 
Accessibility of nucleosomal DNA highly regulated and is orchestrated by many 
proteins that combinatorially alter the positional phasing of nucleosomes by 
chromatin remodeling enzymes, substitution of variant histones, post-translational 
modification of nucleosomes and the partitioning of chromatin into specific nuclear 
locations.  
 
X chromosomal regulation by the process of dosage compensation provides an ideal 
model system to study the effect of chromatin and epigenetic factors on gene 
expression. In mammals, genes on the active X (Xa) chromosome are upregulated 
about twofold, with a corresponding inactivation of one of the two X chromosomes 
(Xi) ensuring equivalent sex chromosome expression in males and females. In 
Drosophila, dosage compensation is accomplished by the work of the MSL complex, 
which provokes a two-fold increase in the expression of genes on the male X 
chromosome. The MSL complex specifically binds to genes that require to be 
unregulated and, through the action of MOF, a histone acetyltransferase subunit 
within the complex, induces acetylation of H4K16, which is associated with an 
increase in the rate of transcription of genes. 
 
In contradiction to the classic view that MOF was restricted to the male X 
chromosome, it has been found recently by our lab that MOF binds to multiple sites 
on the autosomes in both sexes. This suggests that MOF has a role in transcriptional 
regulation beyond dosage compensation. The work presented in this thesis shows the 
purification of a novel complex of evolutionary conserved proteins, which contains 
MOF. We termed the complex the NSL complex (Non-Specific Lethal), as mutation 
of proteins of the complex is lethal to both sexes. The NSL complex is composed of 
the evolutionary conserved proteins MOF, NSL1, NSL2, NSL3, MCRS2, MBDR2, 
WDS, Z4 and Chromator. These components of the NSL complex broadly decorate 
all chromosomes, and overlap with MOF on the X chromosome(s), as well as on all 
autosomes in males and females. Colocalization of NSL complex members with MOF 
occurs at the level of individual genes, with NSL associated with the promoters of 
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MOF-bound genes. Analysis of total RNA from fly lines expressing RNAi against 
NSLs specifically in salivary glands demonstrates that the binding of the NSL 
complex to promoters is functional, as there is a strong correlation between the 
absence of NSL and a decrease in transcription in males and females. Taken together, 
work performed in this thesis demonstrates that the NSL complex functions as a novel 
transcription regulator in Drosophila.  
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ZUSAMMENFASSUNG 
 
 
Chromatin besteht aus DNA, die sich um Nukleosomen herumwindet. Die 
Nukleosomen haben voneinander einen mittleren Abstand von etwa 200 Basenpaaren 
(bp). Eine Regulation von Genexpression findet statt, indem der Zugang der RNA-
Polymerase zur DNA durch Umbau der Chromatinstruktur (“chromatin remodeling”) 
und kovalente Modifikation von Histonen moduliert wird. Diese Vorgänge werden 
durch eine Vielzahl an Proteinen gesteuert, die in kombinatorischer Weise die 
Position und den Abstand der Nukleosomen zueinander verändern, Histonvarianten 
substituieren, Nukleosomen posttranslationell modifizieren und das Chromatin in 
spezifischen Regionen des Zellkerns positionieren.  
 
Der Prozess der Dosis-Kompensation (“dosage compensation”) bietet ein 
Modellsystem, um epigentische Mechanismen der Expressionsregulation zu 
untersuchen. In Säugern werden Gene auf dem aktiven X-Chromosom (Xa) auf etwa 
die zweifache Dosis hochreguliert, korrespondierend zu einer Inaktivierung eines der 
beiden X-Chromosomen (Xi), wodurch eine äquivalente Expression der Gonosomen 
in Männchen und Weibchen sichergestellt wird. In Drosophila wird Dosis-
Kompensation durch den MSL-Komplex erreicht, der eine Verdoppelung der 
Expression von Genen auf dem männlichen X-Chromosom bewirkt. Der MSL-
Komplex bindet spezifisch an Gene, die hochreguliert werden müssen und induziert 
mittels seiner Komplexuntereinheit MOF, einer Histonacetyltransferase, die 
Acetylierung von H4K16, welche mit einer gesteigerten Transkriptionsrate assoziiert 
ist.  
 
Im Gegensatz zu der klassischen Annahme, dass MOF auf das männliche X-
Chromosom beschränkt sein solle, wurde vor kurzem gezeigt, dass MOF in beiden 
Geschlechtern an viele Regionen auf Autosomen bindet. Dies lässt vermuten, dass 
MOF eine über die Dosis-Kompensation hinausgehende Rolle bei der 
Transkriptionsregulation spielt. Die hier vorgestellte Arbeit beschreibt die 
Aufreinigung eines neuen MOF-enthaltenden Komplexes konservierter Proteine, Wir 
haben ihn NSL-Komplex genannt (“Non-Specific Letal”/unspezifisch letal), da 
Mutation von Komplexkomponenten in beiden Geschlechtern letal ist. Der NSL-
Komplex setzt sich zusammen aus den konservierten Proteinen MOF, NSL1, NSL2, 
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NSL3, MCRS2, MBDR2, WDS, Z4 und Chromator. Die NSL-Komponenten 
interagieren über weite Strecken mit sämtlichen Chromosomen und überlappen dabei 
an vielen Stellen auf dem X-Chromosom (bzw. den X-Chromosomen) wie auch auf 
allen Autosomen mit MOF, sowohl in Männchen wie auch in Weibchen. Die 
Kolokalisation der NSL-Komponenten mit MOF geschieht auf der Ebene 
individueller Gene, wobei NSL mit dem Promotor MOF-gebundener Gene assoziiert. 
Die Analyse von Gesamt-RNA isoliert aus Drosophila-Linien, die eine RNAi gegen 
NSLs spezifisch in den Speicheldrüsen exprimieren, zeigt dass die Bindung des NSL-
Komplexes an Promotoren funktionell relevant ist, da eine starke Korrelation 
zwischen der Abwesenheit von NSL und einer Abnahme der Transkription in 
Männchen und Weibchen beobachtet wurde. Diese Ergebnisse legen nahe, dass der 
NSL-Komplex eine allgemeine Rolle bei der Transkriptionsregulation spielt. 
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1. INTRODUCTION 
 
 
1.1. Chromatin 
Chromatin was named by Walter Flemming, who in 1882 observed the “nuclear 
scaffold” within nuclei, that could be visualized easily by staining with basophilic 
reagents. Chromatin literally means a “coloured, lightened material”, and today we 
know that it consists of the complex combination of DNA, RNA and protein that 
makes up chromosomes. 
 
Chromatin is intra-nuclear within eukaryotic cells and present in the nucleoid in 
prokaryotic cells. It can be differentiated into heterochromatin (densely staining, 
condensed, inactive) and euchromatin (lightly staining, extended, active, generally 
found close to the nuclear periphery) (Frenster, 1965). 
 
The major components of chromatin are DNA and histone proteins; however, many 
other chromosomal proteins have prominent roles, too. The essential functions of 
chromatin are to compact long molecules of DNA into a smaller volume to fit in the 
cell, to physically protect DNA, to strengthen and to compact the DNA to allow 
mitosis and meiosis to occur and, to provide a platform to regulate expression, DNA 
replication and DNA repair when needed. By physically achieving these complex 
roles, chromatin ensures a high fidelity of tra nsmission of genetic information from 
one generation to another. 
 
1.2. Chromatin organization 
 
The smallest brick of chromatin is a nucleosome (Kornberg, 1974). Nucleosomes are 
composed of two copies of canonical (core) histones, H2A, H2B, H3 and H4, which 
together comprise a histone octamers (Luger et al. 1997). Core histone proteins are 
small, highly basic molecules with two distinct domains: a globular compact core, and 
a flexible amino-terminal tail (Fig. 1, A). Their globular domains are composed of 
helix-turn-helix domains, which stack in the quaternary structure to promote 
oligomerisation. In contrast, the tail is unstructured, protrudes from the histone 
octamer and serves as a template on which are written a series of post-translational 
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covalent modifications, known as the histone code (Fig. 1, B). Nucleosome provides a 
scaffold structure, around which 147 bp of DNA make approximately 1.7 turns. 
Nucleosomes are separated from each other by linker DNA, which is generally 200 bp 
long. More recently, it has become apparent that nucleosome position is non-random 
and is intrinsically encoded within primary DNA sequence. Additionally, ATP-driven 
remodeling complexes act on nucleosome position to regulate access of proteins to 
cis-acting elements on DNA (Davey et al. 2002).  
 
 
 
Figure 1. A. Structure of nucleosomal histones. B. Amino-terminal tails of core 
histones. The numbers indicate amino acid position. The post-translational 
modifications are indicated (red ac = acetylation sites; blue p = phosphorylation sites; 
green m = methylation sites; purple rib = ADP ribosylation) (Ridgway et al., 2002).  
 
Chromatin at this initial level of a nucleosomal organization is 11 nm thick, has the 
appearance of “beads on a string” and is present as an accessible, active and largely 
unfolded interphase conformation (Fig. 2.). The interaction between nucleosomes and 
DNA is predominately altered by cis- and trans-effects of covalently modified histone 
tails. 
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Figure 2. Each DNA molecule overgoes several levels of compaction, from a double 
helix into a mitotic chromosome that is 10.000 times shorter than its extended length 
(Felsenfeld and Groudine 2003) 
 
cis-Effects are dictated through changes in physical properties of histone tails. 
Modulation of either the electrostatic charge or tail structure alters internucleosomal 
contacts. Acetylation of lysines and phosphorylation of serine and threonine residues 
are the most pronounced of such examples, when positive charges on highly basic 
histone tails are neutralized or negative charges are introduced to the histone tail; this 
generates a local expansion of chromatin fiber. In this relaxed state of chromatin, 
promoter elements are accessible to transcription factors and to the basal transcription 
machinery. In addition, an accumulation of negative charges can result on charge 
patches on chromatin, which can also alter nucleosomal packaging (Dou and 
Gorovsky 2000). trans-Effects result from the recruitment of modification-binding 
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elements to the chromatin. Many proteins, usually through discrete binding domains, 
have a specific affinity to particular histone modifications. Such recognition provides 
a platform for other proteins, frequently members of large enzymatic complexes, to 
associate with and further modify chromatin. For example, a bromodomain recognizes 
acetylated histone residues, and is often a part of histone acetyltransferase (HAT) 
enzymes, which in turn are associated with chromatin-remodeling complexes, that 
increase local DNA accessibility (Dhalluin et al. 1999; Jacobson et al. 2000). 
Methylated lysine residues are read by chromodomains, or similar domains, such as 
MBT or tudor (Bannister et al. 2001; Lachner et al. 2001). In this way, the addition 
and removal of specific post-translational histone modifications result in concerted 
regulatory effects on chromatin function. ATP-dependent remodeling complexes play 
a particular physical role in regulating gene expression. Their activity can result in 
octamer sliding, alteration of nucleosomal structure by DNA looping, or replacement 
specific canonical histones by their variants. These non-covalent modifications 
change positions of nucleosomes to expose or conceal DNA sequences, thereby 
regulating their physical exposure to molecular complexes, such as the basal 
transcription machinery (Narlikar et al. 2002). 
 
The next level of chromatin compaction is to 30nm fibers. Nucleosome are stabilized 
by a linker histone H1, that associates at the entry and exit point of DNA on the core 
nucleosome, and/or by chromatin associated factors, such as heterochromatin protein 
H (HP1) or Polycomb (PC) (Fan et al. 2005). At this stage of organization, chromatin 
is looped and compressed about approximately 50 fold. Further compaction then 
results in 300-700 nm fibers that are fixed through anchoring to the nuclear periphery 
via chromatin associated factors, such as nuclear lamins. There is evidence that this 
high-order geography of chromatin is associated with distinct functional nuclear sub-
domains, such as the clustering of active chromatin sites to RNA polymerase II 
transcription factories, or around replicating DNA and DNA polymerase, or to 
“silent” chromatin domains, such as pericentromeric foci. The dynamics and 
correlation between active or silent chromatin configuration with particular nuclear 
positioning remains poorly defined and subject to intense research activity.  
 
DNA is at its most compact in metaphase chromosomes, both during meiosis or 
mitosis. This high condensation of DNA achieves equal distribution of sister 
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chromosomes between daughter cells. The 10.000 fold compaction is promoted by 
hyperphosphorylation of histones H1 and H3, the action of ATP-dependent 
complexes of condensin and cohesin, and super-coiling driven by the activity of 
topoisomerase II.  
 
1.3. Chromatin dynamics and regulation of gene expression 
 
Chromatin is subject to many different modifications and changes in its structure. It is 
achieved through tuned work of many regulatory proteins and results in chromatin 
remodeling, as well as appearing of covalent marks on it (Fig. 3). Following part of 
the introduction is focused on nucleosome remodeling and histone modifications. 
 
1.3.1. Nucleosome remodeling  
 
As discussed, DNA is wrapped around nucleosomes and is then further condensed at 
several levels. However, for processes such as gene expression, DNA repair and 
replication, large molecular assemblies have to gain access to DNA. This is achieved 
by dynamic alteration to the structure of chromatin that is fulfilled by several 
complexes, which either do not require energy, or are dependent on ATP hydrolysis. 
Energy independent processes generally act to covalently modify the amino terminal 
histone tails. Energy-dependence is a property of chromatin remodeling complexes, 
with the result of this work being the movement of histone octamers relative to DNA. 
Chromatin remodeling is consequently used to regulate access to specific DNA 
sequences. Both mechanisms are functionally interconnected, and both are required 
for opening chromatin structure to achieve activation of transcription, DNA repair and 
replication (Gangaraju and Bartholomew 2007) 
 
There are five families of ATP-dependent remodeling complexes, classified upon the 
nature of their ATPase unit: the SWI/SNF, ISWI, Mi-2/NuRD, INO80, and 
SWR1families (Bao and Shen 2007). 
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Figure 3. Chromatin provides a structural platform that is subject to extensive post-
translational modifications: methylation, acetylation, phosphorylation and 
ubiquitination of specific histone residues; methylation of CpG dinucleotides; 
exchange of histones (a); changes in the relative position of the nucleosomemediated 
byATP-dependent remodeling complexes (b); induction of double-stranded DNA 
breaks by topoisomerase II (c) and the generation of single-stranded DNA breaks by 
topoisomerase I (d) (Reid et al. 2009). 
 
 
1.3.1.1. SWI/SNF family 
 
The 11-subunit SWI/SNF complex was the first chromatin remodeling factor to be 
discovered (Gangaraju and Bartholomew 2007). It was identified genetically as a 
regulator of mating type switching (SWI) and as required for growth on nutrient 
sources other than sucrose – thus SNF, sucrose nonfermenting (Peterson and 
Herskowitz 1992; Sudarsanam and Winston 2000). In S. cerevisiae, Drosophila and 
humans, there are two versions of the SWI/SNF complex: RSC and SWI/SNF. RSC is 
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more abundant and is essential for the cell growth, where as SWI/SNF is less present 
and is not critical for the growth (Du et al. 1998). 
 
SWI/SNF is required for telomeric silencing and for silencing transcription of rRNA 
genes by RNA polymerase II (Dror and Winston 2004). It is also involved at an early 
step in homologous recombination, where RSC also acts at the stage of strand 
invasion (Chai et al. 2005; Huang et al. 2005). SWI/SNF also participates  in sister 
chromatid cohesion and chromosome segregation (Huang et al. 2004; Huang and 
Laurent 2004) (Chang et al. 2005). 
 
In Drosophila, the two forms of SWI/SNF are called BAP (Brahma associated 
proteins) and PBAP (Polybromo-associated BAP), and both share the same catalytic 
subunit (Brahma) (Mohrmann and Verrijzer 2005). In humans, the homologues are 
known as BAF (BRG1/hBRM-Associated Factors) and PBAF (Polybromo-associated 
BAF). However, there are many forms of human SWI/SNF that acquire tissue-
specific subunits (Wang 2003) or additional sub-complexes, where the SWI/SNF-type 
remodelers become associated with other factors, such as BRCA1 (Bochar et al. 2000) 
(Decristofaro et al. 2001), components of the histone deacetylase Sin3 complex (Sif et 
al. 2001) and histone methylases (Pal et al. 2003; Pal et al. 2004). The action of 
SWI/SNF increases nucleosome mobility, through propagating DNA loops around the 
nucleosome surface  by provoking a transitory disruption of DNA-nucleosome 
contacts (Aoyagi et al. 2002). SWI/SNF makes nucleosomal DNA accessible by 
creating loops on nucleosome surface. This does not alter nucleosome but brings 
DNA sequences into linker regions. This results in DNA becoming accessible to 
either transcription activators or to repressors (Gangaraju and Bartholomew 2007). 
 
1.3.1.2. ISWI family 
 
An in vitro assay for activities allowing transcriptional factor access to sites in 
nucleosomal arrays (Tsukiyama et al. 1995; Varga-Weisz et al. 1997) identified two 
chromatin remodeling enzymes, dNURF and dCHARC, the founding members of a 
growing ISWI family. Additionally chromatin remodelers belonging to this group 
have been identified in yeast, humans, mouse and Xenopus. Because of the similarity 
of their ATPase subunit to the SWI2 ATPase of the SNF2 subfamily, this class of 
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remodelers became known as Imitation SWItch (ISWI). The ATPase of ISWI type is 
characterized by the presence of a SANT (SWI3, ADA2, N-CoR and TFIIIB B) 
domain and by the absence of a bromodomain (Grune et al. 2003). There are 
indications that SANT domains might be responsible for the nonspecific binding of 
ISWI complexes to DNA and their resulting preferential biding to de-condensed 
nucleosomes with exposed linker DNA over nucleosomes associated with histone H1 
(Langst et al. 1999). In general, ISWI complexes are smaller (300-800 kDa) and have 
2-4 subunits, in comparison to larger complexes (up to 2mDa) from three other 
families which may contain up to 15 units. 
 
In Drosophila, there are three complexes in the ISWI family: NURF, ACF and 
CHRAC. NURF (Nucleosome Remodeling Factor) was first identified by its 
requirement to induce accessibility of the hsp70 heat shock promoter in the presence 
of the GAGA transcription factor (Tsukiyama et al. 1995). The complex is composed 
of four subunits: BPTF/Nurf301, ISWI, Nurf-38 and Nurf-55 (Tsukiyama and Wu 
1995). NURF interacts with the histone H4 N-terminal tail and this interaction is 
essential for its ATPase and nucleosome mobilization activity (Georgel et al. 1997). 
The ATPase activity is stimulated by nucleosomes but not by DNA, in contrast to the 
SWI/SNF complex, where nucleosomes and DNA equally stimulate  ATPase activity. 
NURF activates transcription in vivo and in vitro (Mizuguchi et al. 1997), and is 
achieved by mobilizing nucleosomes along the DNA. This requires the largest subunit 
of NURF – NURF301.  
 
ACF (ATP-utilizing chromatin factor) is another NURF multisubunit complex. It 
processively deposits histone octamers along DNA to form long periodic arrays of 
nucleosomes (Ito et al. 1997; Fyodorov and Kadonaga 2002). ACF is a major 
chromatin assembly protein in Drosophila. Cells lacking it proceed more rapidly 
through S phase due to the lack of resistance from chromatin, as these complexes are 
involved in the formation of repressive chromatin. 
 
CHRAC (chromatin accessibility complex) is a further ISWI containing complex, that 
additionally contains Acf1 and two histone fold containing proteins, CHARC-14 and 
CHRAC-16 (Varga-Weisz et al. 1997). Both CHARC subunits are involved in early 
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Drosophila development (Corona et al. 2000). CHRAC can also generate nucleosome 
arrays with regular spacing. 
 
Human orthologues of ISWI (SNF2H and SNF2L) are incorporated into many 
complexes (Corona and Tamkun 2004) that work in transcription initiation, 
repression, elongation, termination and sister chromatid cohesion. The smooth 
functioning of these complexes are important for many developmental programmes to 
be fulfilled: defined examples include muscle (de la Serna et al. 2001; Simone et al. 
2004; de la Serna et al. 2005; Ohkawa et al. 2006), heart (Lickert et al. 2004), blood 
(Vradii et al. 2006), skeletal (Young et al. 2005), neuron (Battaglioli et al. 2002; 
Olave et al. 2002; Seo et al. 2005; Matsumoto et al. 2006), adipocyte (Salma et al. 
2004), liver (Inayoshi et al. 2006) and immune system/Tcell development (Gebuhr et 
al. 2003; Mudhasani and Fontes 2005). 
 
In general, ISWI family chromatin remodeling complexes modulate nucleosomal 
DNA accessibility, by moving the entire nucleosome to either place the DNA site into 
the linker DNA region to increase accessibility or to move DNA onto the surface of 
the nucleosome, to decrease ease of access. ISWI is mostly involved in establishing a 
repressive chromatin environment (Gangaraju and Bartholomew 2007). 
 
1.3.1.3. CHD family 
 
CHD-1 (chromodomain-helicase DNA binding protein) was isolated from mouse and 
contains features of both the Swi2/Snf2 family of ATPase and of the Polycomb/HP1 
chromodomain family of proteins (Delmas et al. 1993; Tsukiyama and Wu 1997).  
CHD1 has a minor groove DNA binding motif (Stokes and Perry 1995). In 
Drosophila it is found on polytene chromosomes, and is localized to interbands and 
puffs, which are regions of high transcriptional activity (Stokes et al. 1996). In 
contrast to the polycomb/HP1 complex, it is not localized to condensed chromatin. 
Both the chromo- and helicase domains of CHD1 are required for association with 
chromatin.  
 
1.3.1.4. INO80 and SWR1 family 
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INO80 and SWR1 are both large complexes, containing 14 and 15 units, of which 
four are common between both complexes. INO80 and SWR1 are involved in 
transcription activation and DNA repair. The largest subunits of both complexes 
contain a conserved ATPase/helicase domain that is divided by a large spacer, 
whereas similar domains in other members of the SNF2 superfamily (Swi2/Snf2 and 
ISWI) are continuous (Shen et al. 2000). Yeast strains lacking INO80 mis-regulate 
transcription and are also hypersensitive to DNA-damaging agents, suggesting that 
INO80 regulates transcription and is involved in DNA repair (Morrison et al. 2004; 
van Attikum et al. 2004). 
 
1.3.2. Histone modifications 
 
Histones are highly conserved proteins; however, chromatin is not a uniform 
structure. Extensive post-translational modification, particularly to the unstructured 
N-terminal tail, generates local diversity in histone structure. It was initially shown 
that histones carry acetyl, methyl and phosphate groups; later, histones were the first 
discovered proteins substrates for ubiquitination (Robzyk et al. 2000; Wang et al. 
2004). At first, a correlation between histone posttranslational modification (HPTMs) 
and their role in the regulation of gene expression was not obvious, with, many 
believing that there could not be a link between nucleosome modification and the 
transcriptional state of chromatin. However, a direct connection between gene 
regulation and nucleosome modification has been established. Indeed, post-
translational modification of nucleosomes and nucleosome positioning can be 
maintained through cellular division, giving rise to an epigenetic role for the 
information content of nucleosomes in chromatin function.  
 
All histone PTMs can be divided into two groups, dependent on the size of the 
covalent modification. Either small residues, such as acetyl, methyl and phosphate 
groups, can be added, often in combination, to nucleosomes or larger peptides, such 
as ubiquitin and SUMO may be added. The influence of PTM in gene regulation 
differs for each modification. They can directly affect the conformation of chromatin, 
through structural changes affecting nucleosomal or even higher-order organizations. 
HPTMs may also disrupt binding of chromatin or histones associated proteins. 
HPTMs also generate alternative binding surfaces, and by so doing, provide 
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interaction surfaces that can be interrogated by transcription factors. The information 
content generated by combinatorial covalent modifications at multiple sites on each of 
the four histones, known as the histone code, is interpreted by proteins that interact 
with each modification. The consequence of these interactions can be gene activation, 
gene repression or further sequential modification of the local histone information 
content. This results in changes in transcription. In the following part of the 
introduction, more details of HPTMs will be given. 
 
1.3.2.1. Acetylation  
 
The presence of acetylayed histones correlates with transcriptionally active regions, 
which usually have an open chromatin configuration that is accessible to large 
molecular probes, such as DNase and MNase. In the mid-90’s, the first nuclear 
histone acetylation and deacetylation enzymes were identified, providing the first 
direct evidence that these enzymes play a role in transcription. The first nuclear 
histone acetyltransferase was isolated form Tetrahymena macronucleus (Brownell et 
al. 1996), and was found to be homologous to a previously isolated transcriptional 
coactivator in S. cerevisiae, Gcn5. In turn, Gcn5 was known to interact with 
transcriptional activators. Following this, the first histone deacetylase (HDAC) was 
isolated by biochemical purification (Taunton et al. 1996). This enzyme was 
homologous to the yeast transcriptional regulator Rpd3p, which was defined 
previously as having a cofactor role in gene expression. Collectively, these 
discoveries established a model, where DNA-bound activators recruit HATs to 
acetylate nucleosomal histones, with repressors targeting HDACs to de-acetylate 
histones. These alterations change the charge and structure of the nucleosome and 
regulate gene expression. 
 
Many coactivators and corepressors possess HAT or HDAC activity, or associate with 
such enzymes (Sterner and Berger 2000; Roth et al. 2001); this enzymatic activity is 
crucial in gene activation. HATs and HDACs are often components of complexes, and 
the histone-modifying activity of them is just one function, and others include, for 
example, the recruitment of TBP (Grant et al. 1998). Some nuclear hormone 
receptors, for example, when bound to ligand, function as DNA-binding 
transcriptional activators, and when not bound, as transcriptional repressors. This is 
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predominately achieved by recruiting HATs to acetylate target chromatin regions 
when liganded, and by recruiting HDAC activity when not (Baek and Rosenfeld 
2004). 
 
There are three families of HAT proteins. They are distinguished by their targets. For 
the major HAT family, GNAT, (Gcn5 related acetyltransferase), histone H3 is the 
main target. CBP/p300 family is able to target both H3 and H4. Another large family, 
MYST, characterized by the presence of a chromodomain, targets histone H4. 
Depending on their specificity, enzymes of the MYST subfamily are divided into two 
groups: those that exclusively acetylate H4K16 in vivo (MOF and hMOF) (Smith et 
al. 2005), and those that acetylate all four terminal lysines on H4, such as Eas1, an 
essential SAS-related acetyltransferase 1 protein in yeast (Smith et al. 1998). Many 
HATs contain bromodomains which reinforce their association with acetylated 
histones (Hassan et al. 2002).  
 
1.3.2.1.1. MYST family  
 
A large part of the work described in this thesis is related to the histone 
acetyltransferase MOF from the MYST family. This family was first described in 
1996 and originally named so by the name of its four founding members in yeast and 
mammals: MOZ, YBF2/SAS3, SAS2 and TIP60 (Borrow et al. 1996; Reifsnyder et 
al. 1996). The defining feature of HATs in this family is the presence of the highly 
conserved MYST domain composed of an acetyl-CoA binding domain and a zinc 
finger; some members of this family also have additional structural features such as 
chromodomains, plant homeodomain-linked (PHD) zinc fingers (Utley and Cote 
2003; Yang 2004). They are parts of evolutionary conserved multisubunit complexes 
which play key roles in post-translational modifications of histones and by doing this 
influence on chromatin structure. Malfunctions of MYST HATs are linked to a 
number of human diseases including cancer (Avvakumov and Cote 2007). One of the 
members of the MYST family is a histone acetyltransferase MOF, which is an 
essential part of the dosage compensation machinery in Drosophila. Since the major 
part of the thesis is dedicated to this process, the next paragraph describes this protein 
in more details.  
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1.3.2.1.1.1. MOF  
 
MOF, histone acetyltransferase from the MYST family, was first described in 
Drosophila screen for mutations that affect only male flies (Hilfiker et al. 1997). It is 
a key component of the dosage compensation complex (Akhtar and Becker 2000; 
Smith et al. 2000), and is a catalytic subunit of this complex with an enzymatic 
specificity to H4K16 residue (Turner et al. 1992); consequently, male X chromosome 
is hyperacetylated (Hilfiker et al. 1997). Although MOF is also capable of acetylating 
MSL3 (Buscaino et al. 2003) and MSL1 (Morales et al. 2004), its preferred substrate 
is histone 4 (Akhtar and Becker 2000; Smith et al. 2000), and the substrate specificity 
to H4 acetylation is increased upon integration into the dosage compensation complex 
(Morales et al. 2004). Solving the structure of MOF revealed that a putative chromo 
domain of it is organized by five beta strands, which are different from the alpha+beta 
fold of the canonical chromo domain, and was named a chromo-barrel domain, CBD. 
The domain shares a common fold with several other chromatin-associated modules, 
such as MB-like repeat, Tudor, and PWWP domains (Nielsen et al. 2002), which 
might mean that a chromo-barrel is an intermediate structure in the evolution of 
canonical chromo domains to these other modules, or vice versa (Nielsen et al. 2002). 
CBD and its adjacent lysine-rich region are engaged in RNA binding activity in vivo 
and in vitro, and a conserved tyrosine is important for this interaction (Akhtar and 
Becker 2000; Akhtar et al. 2000; Nielsen et al. 2005). Apart from the CBD, MOF also 
has a HAT domain, which activity is stimulated upon the interaction with MSL3 
(Morales et al. 2004) and is required for specific acetylation of H4K16 (Smith et al. 
2000; Akhtar and Becker 2001). Point mutation in HAT domain causes male specific 
lethality (Hilfiker et al. 1997). The third domain that MOF has is a zinc finger, a 
domain known to bind DNA.  
 
1.3.2.2. Deacetylation 
 
There are many HDACs that remove acetyl mark on histones, with at least 10 histone 
deacetylases been identified in S. cerevisiae and 19 in humans (Yang and Seto 2003; 
Keogh et al. 2005). They are categorized into three groups that are conserved from S. 
cerevisiae to mammals. Type I and Type II are hydrolases that contain Zn2+ at their 
catalytic site, whereas Type III, the Sir2-related enzymes, require the cofactor NAD+ 
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as to achieve hydrolytic cleavage of the acetyl group. Many HDACs are found in 
large multisubunit complexes that target enzymes to promoters to induce 
transcriptional repression. For example, Rpd3 is a part of a complex which includes 
the HDAC Sin3. Rpd3 is also a part of a complex that binds to open reading frames 
through a chromodomain mediated association with H3K36me. This results in histone 
deacetylation, which suppresses DNA pol II initiation (Carrozza et al. 2005; Joshi and 
Struhl 2005). 
 
1.3.2.3. Phosphorylation  
 
Phosphorylation is a very well characterized post-translational modification 
frequently involved in regulatory pathways and in signal transduction from the cell 
surface, through the cytoplasm and into the nucleus, resulting in changes to gene 
expression. Correspondingly, it was discovered that when cells were stimulated to 
proliferate, a set of immediate-early genes were induced to become transcriptionaly 
active. Increased gene expression correlated with histone H3 phosphorylation 
(Mahadevan et al. 1991). 
 
Serine 10 of histone H3 is an important phosphorylation site regulating transcription 
from yeast to human, including Drosophila. A high density of H3S10 phosphorylation 
correlates with chromosome segregation during mitosis and meiosis. Although 
remaining rather unclear, or may be that phosphorylation induced charge 
neutralization of residues around S10H3 thereby allowing compaction to occur 
(Nowak and Corces 2004). 
 
The mechanistic role of histone phosphorylation remains largely undefined. There are 
currently three views on what the influence of this modification is. In line with the 
proposal for chromosome condensation, work in Tetrahymena has demonstrated that 
the patch of negative charge induced by phosphorylation influences nearby residues, 
including linker histone H1, to decrease the affinity between the nucleosome and 
DNA. This increases the transcriptional potential of the local chromatin environment 
(Dou and Gorovsky 2002). Secondly, proteins bound to chromatin can be dislodged 
by phosphorylation, as shown by the lowered binding affinity of HP1 during mitosis 
subsequent to mitosis-specific H2S10 phosphorylation (Fischle et al. 2005; Hirota et 
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al. 2005). Thirdly, transcriptional regulation may be influenced by recruitment of 14-
3-3 adaptor proteins to phosphorylated H2S10 (Macdonald et al. 2005). 
 
1.3.2.4. Methylation 
 
Histone methylation is diverse and complex and can be present on either lysine or 
arginine residues. The consequence of methylation upon transcriptional regulation can 
be either positive or negative, depending on the position of methylated residue within 
the histone. A further layer of complexity is that each residue can be multiple 
methylated, with lysines either mono (me1), di- (me2) or tri- (me3) methylated; 
whereas arginines can be mono- or dimethylated; dimethylation can either be 
symmetrical or asymettrical. As 24 lysine and arginines are available on H2A, H2B, 
H3 and H4 in total, one can imagine that there is a huge combinatorial potential of 
methylated nucleosomes. This diversity allows fine tuning of complex and dynamic 
processes, such as the regulation of gene expression regulation (Jenuwein and Allis 
2001; Zhang and Reinberg 2001; Lee et al. 2005).  
 
The number of all theoretically possible combinations of different methylated states in 
a given protein, provided all lysines and arginines can be methylated, is: 
 
4K·4R-1 
 
where K is a number of lysines, and R – number of arginines in the protein. 
 
It has long been known that histones are methylated; however the biological role of 
methylation was elucidated only recently, following the discovery of the first 
methyltransferase that uses histones as substrate (Rea et al. 2000). Today, many more 
histone methyltransferases, along with their sites of modification on histones, have 
been characterized (Martin and Zhang 2005). The common feature of all 
methyltransferases is the occurrence of a SET domain, with the only exception being 
Dot1. The SET domain contains a catalytic active site to which the methyl donor S-
adenosyl-L-methionine cofactor binds. 
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Table 1. Histone lysines. 
Modified 
residue 
Effects References 
H3K4 
di-methylation occurs on inactive and active euchromatic 
genes; 
tri-methylation is present exclusively on active genes; 
can result in recruitment of specific factors; 
H3K4 is prevented in vitro, when H3K4 is methylated and 
H3S10 is phosphorylated, it might function to block 
repressive H3K9 methylation on actively transcribed genes. 
(Litt et al. 2001) 
(Noma et al. 2001) 
(Santos-Rosa et al. 2002) 
(Sims et al. 2005) 
(Li et al. 2006) 
(Zhang and Reinberg 
2001) 
H3K36 
present on the coding region of active genes and is thought 
to be necessary for efficient elongation of transcripts; 
mono-ubiquitylation of Lys 123 of H2B represses H3K36 
methylation; 
may repress transcriptional initiation when is  present on 
promoters of inducible genes. 
(Zhang and Reinberg 
2001) 
(Carrozza et al. 2005) 
(Joshi and Struhl 2005) 
(Keogh et al. 2005) 
(Zhang and Reinberg 
2001) 
H3K79 
present in euchromatic regions and in the transcribed region 
of active genes in yeast; 
restricts recruitment of the transcriptional repressors and by 
enhancing their concentration at repressive chromatin 
regions contributes to establishment and maintenance of 
silent heterochromatin; 
yeast H3K79 lysine methyltransferasse Dot1 is involved in 
the DNA repair checkpoint. 
(Martin and Zhang 2005) 
(Huyen et al. 2004) 
(Okada et al. 2005) 
H3K9 
involved in silencing chromatin; 
creates a binding platform for HP1. 
(Rea et al. 2000) 
(Bannister et al. 2001) 
(Lachner et al. 2001; 
Nakayama et al. 2001) 
H3K27 
repressive mark, present at pericentromeric 
heterochromatin, at the inactive X chromosome in 
mammals, and in euchromatic gene loci that contain, in 
case of Drosophila, polycomb response elements, PREs; 
is a binding site for a Polycomb. 
(Cao and Zhang 2004) 
(Cao et al. 2002) 
(Czermin et al. 2002) 
(Muller et al. 2002) 
(Kuzmichev et al. 2002) 
(Fischle et al. 2003; Min 
et al. 2003) 
H4K20 
one of the less studied modifications; 
involved in the maintenance of heterochromatin and cell-
cycle control; 
linked to DNA repair in budding yeast. 
(Karachentsev et al. 
2005) 
(Julien and Herr 2004) 
(Sanders et al. 2004) 
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The best characterized lysine sites of histone methylation are five on histone H3 
(lysines 4, 9, 27, 36 and 79) and one on histone H4 (lysine 20) (Table 1.). 
Modification of three of these sites (H3K4, H3K36 and H3K79) induces 
transcriptional activation, with the remainder imposing repression (for review see 
Martina and Zhang, 2005). In addition to regulation of gene expression, methylation 
of H3K79 and H3K20 has been shown to be involved in the DNA repair.  
 
1.3.2.5. Deimination 
 
Arginine methylation is reversed through four activities: (i) the peptidylarginine 
desiminase PADI4 converts mono-methylated arginines to citrulline (Cuthbert et al., 
2004; Wang et al., 2004); (ii) LSD1 (lysine-specific demsethylase 1) is an amine 
oxidase that demethylates H3K4me1 and H3K4me2 (Shi et al., 2004); (iii) di-
oxygenases, characterised by a JmjC domain, demethylate mono- and di-methylated 
histones (Trewick et al., 2005; Tsukada et al., 2006); and (iv) the protein JMJD2C 
acts to demethylate H3K9me2 and me3 through a hydroxylation reaction requiring 
iron and alpha-ketoglutarate as cofactors (Cloos et al., 2006). 
 
No enzyme directly capable of demethylating methylated arginine was found, which 
lead to a suggestion that probably there are other types of enzymatic reactions that 
may antagonize arginine methylation (Bannister et al. 2002). One of them is 
deimination. It is a process by which an arginine can be converted to citrulline via the 
removal of an imine group. Deimination of monomethylated arginine would result in 
the removal of methylamine group from arginine. In recent studies they have 
demonstrated the presence of citrulline in histones and identified the enzyme that 
converts arginines within histones into citrulline (Cuthbert et al. 2004; Wang et al. 
2004; Wang et al. 2004). Also, the appearance of citrulline on histones H3 and H4 
coincides with the disappearance of arginine methylation in vivo. Analysis of 
estrogen-regulated promoter, where arginine methylation correlates with the active 
state of transcription, has shown that citrulline appears with the promoter is shut off.  
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1.3.2.6. Ubiquitylation, deubiquitylation and sumoylation 
 
In contract to previously described post translational modifications of acetyl or methyl 
groups, histones can also be modified with peptides, such as ubiquitin (Ub) and 
SUMO. Addition of these molecules increases the mass of histones by up to two-
thirds. Ub and SUMO are 18% identical in sequence, and have a similar 3D structure 
and mechanism of ligation to substrates, although their surface charges are different, 
and so are the functional consequences upon ligation to substrates (Shiio and 
Eisenman 2003). Histones were the first example of proteins that are 
monoubiquitylated (polyubiquitylated substrates undergo proteosome mediated 
degredation), although the modified lysine residue (e.g. K119 of H2A) was 
discovered several years later (Robzyk et al. 2000; Wang et al. 2004). 
 
Depending on the modified residue and histone, ubiquitylation can be, as with 
methylation, either repressive or activating. H2B monoubiquitylation activates 
transcription (Kim et al. 2005) and leads to H3K4 methylation (Henry et al. 2003). A 
monoubiquitylation mark on lysine 119 of H2A, in contrast, is repressive (Wang et al. 
2004). Many ubiquitin interaction domains which bind to non-histone ubiquitilated 
substrates have been identified; however, to date, there are no known proteins that 
bind specifically to ubiquitulated histones. 
 
Deubiquitylation of H2BK123Ub promoted both gene activation and heterochromatic 
silencing, achieved through the action of two different proteases: Ubp8 and Ubp10. 
Ubp 8 is a part of the SAGA histone acetylation complex (Sanders et al. 2002) and 
acts following ubiquitylation by Rad6 (Henry et al. 2003; Daniel et al. 2004). It may 
look strange on the first glance, that in order to achieve the result, first the mark has to 
be established, and then erased, but the sequence of H2B ubiquitylation and 
deubiquitylation is necessary to establish the right levels of methylation marks on 
lysines 4 and 36 of histone H3: H3K4 is dependent on H2Ub (and H3K36 does not 
require it) (Henry et al. 2003). Ubp10 works at silenced regions and is important to 
keep low levels of H3K4me and H3/H4, which are markers of transcription repression 
(Gardner et al. 2005). Small ubiquitin-related modifier (SUMO) is a member of a 
growing family of ubiquitin-like proteins involved in HPTM (for reviews see 
(Melchior 2000; Hay 2001; Johnson and Gupta 2001).  
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Histone sumoylation has a generally negative-acting role by preventing activation of 
HPTMs, which can be done via two mechanisms: sumoylated histone directly blocks 
lysine substrate sites (which are otherwise targets of acetylation), or they can also 
mediate transcriptional repression through recruitment of histone deacetylases and 
heterochromatin protein 1 (HP1) (Shiio and Eisenman 2003). 
 
1.4. Dosage compensation as a model of chromatin regulation of gene 
expression 
 
Gene expression is a very complex process, having several levels of regulation. It is 
orchestrated by many regulatory proteins, which lead to a diverse range of events, 
including chromatin remodeling, DNA and histone modifications, as well as 
positioning the chromatin into specific genomic loci.  
 
One of the systems which allow study of gene expression regulation is a dosage 
compensation. Dosage compensation is a regulatory mechanism that ensures equal 
expression of X chromosome linked genes despite the difference in copy number of 
the sex chromosome between males and females. Different organisms have evolved 
diverse ways of compensating unequal distribution of sex chromosomes. In the 
following part of the introduction, evolution of dosage compensation and various 
ways of compensation the unequal amount of genes between sexes are discussed. 
 
1.4.1. Evolution of dosage compensation 
 
Many organisms have different sexes which are distinguished by having a different 
number of sex chromosomes. The defining influence for sex determination can be 
either genetic, and consequently heritable in the species, or external to it. In 
evolutionary terms, males and females had identical chromosomes with sex 
determined by environmental factors, such as temperature. Examples of this 
regulation are seen in some fish and reptile species today, where sex is determined by 
the incubation temperature of the egg, which directly affects sociosexual behavior and 
brain measures (Crews 2003). Environmentaly dependent sex determination has an 
advantage that better-adapted offspring arise under differing environmental 
conditions. However, the existence of the whole species can be compromised upon 
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sudden changes in environment conditions. Indeed, it has been postulated that 
inbalance in sex distribution through the lack of a temperature-independent 
checkpoint might have contributed to the demise of long-extinct reptiles, notably the 
dinosaurs, as a consequence of temperature deviations forcing production of 
predominantly one sex, eventually leading extinction (Miller et al. 2004). 
 
In contrast to environmental sex determination, genetic sex determination defines 
gender at fertilization. Depending on which of the two sexes is homogametic, that is, 
possessing two identical sex chromosomes, two major classes of organisms can be 
distinguished. In most mammals, males are heterogametic (XY) with females being 
homogametic (XX).  In birds and some reptiles, in particular snakes, females are 
heterogametic and have Z and W chromosomes, whereas males have two Z 
chromosomes.  
 
With time, the additional accumulation of sex-specific mutations and genes and 
further divergence of the sex chromosomes has lead to a progressive degradation of 
the sex chromosome specific to the heterogametic sex (W in birds, Y in mammals); 
this may eventially result in the disappearence of the heterogametic chromosome 
(Graves 2006); Ohno 1967). 
 
In consequence of the genetic inbalance arising from the loss of genes on the 
heterogametic sex chromosome, there is the potential that differential gene expression 
occurs between males and females. Inbalanced gene dosage is compensated by 
restricted expresssion of one of the homogametic sex chromosomes, with a number of 
dosage compensation mechanisms evolved in different organisms to deal with 
unequal gene dosage between sexes (Payer and Lee 2008), summarized in the table 2. 
and discussed in details further in this introduction. 
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Table 2. Dosage compensation in different organisms. 
 Birds C. elegans Mammals Drosophila 
Sex 
determination 
ZW/ZZ XX/XO XX/XY X/A ratio 
Dosage 
compensation 
not 
known 
Xx=XO 
X repression 
Xx=XY 
Xi inactivation 
Xa activation  
XY=xx 
X_hypertranscription 
Mechanism 
gene by 
gene 
Condensins 
Polycomb complex 
Polycomb 
complex 
MSL complex 
Protein 
component 
not 
known 
DPY, SDCs, MIX-
1, MES proteins 
BED/Enx1 
BRCA1 
MSLs 
RNA 
component 
not 
known 
not known XIST roX1, roX2 
 
 
1.4.2. Dosage compensation in birds 
 
The mechanism that birds use for dosage compensation is not entirely clear. In ZW 
females, the Z chromosome dosage compensation is incomplete and there are many 
Z-linked genes that have higher expression levels in males compared to females 
(Ellegren et al. 2007; Itoh et al. 2007; Mishra et al. 2007). So far, birds are the only 
example of an organism with a lack of global dosage compensation, providing a case 
of a viable system with large-scale imbalance in gene expression between sexes. 
 
Dosage compensated genes in birds belong mostly to functional groups that differ 
from those of noncompensated. It suggests, that recruitment of dosage compensation 
machinery to genes depends on how important it is to maintain regulation of 
expression levels (Melamed and Arnold 2007). Such genes are mostly localized 
within the male hypermethylated region (MHR) on the Z chromosome. The 
corresponding regions on the female Z chromosome are coated by the noncoding 
MHR RNA and are enriched in H4K16ac mark (Teranishi et al. 2001; Bisoni et al. 
2005). This resembles the situation in Drosophila, where the male X chromosome is 
bound by noncoding roX RNA-containing MSL complex in which induces H4K16 
acetylation. This, in turn, leads to a transcriptional upregulation of the X chromosome 
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(discussed further in this thesis). Correspondingly, a similar model could also be true 
for birds, where MHR RNA recruits a histone acetyltransferase, which evokes a local 
hypertranscription of key genes on the single Z chromosome in female. In addition to 
MHR, DMRT1 also influences dosage compensation and sex determination 
(Teranishi et al. 2001). DMRT1 resides on the Z chromosome, resulting in a double 
dose in ZZ males. The double expression of DMRT1 in gonads of males may induce 
male-specific development (Raymond et al. 1999; Teranishi et al. 2001). This could 
have happened during evolution, as the MHR is adjacent to DMTR1 (Teranishi et al. 
2001). MHR is likely to have been the first gene to become differentiated between the 
sexes and therefore required dosage compensation. Interestingly, DMRT1 itself is not 
hyperacetylated (Bisoni et al. 2005). This could be a mechanism to escape 
compensation to allow DMRT1 to function as a dosage-dependant determinant. 
 
DMRT1 homologues are also involved in male sex determination in Drosophila, C. 
elegans and in vertebrates, including mice and humans (Raymond et al. 1999). 
Temperature-dependent sex determination in turtles and alligators is dependent on the 
expression levels of DMRT1, which is higher in males compared to females gonads, 
implying that DMRT1 links environmental and genetic sex-determination (Smith et 
al. 1999; Kettlewell et al. 2000). 
 
1.4.3. Dosage compensation in Caenorhabditis elegans 
 
In Caenorhabditis elegans, like in flies and mammals, heterogametic XO embryos 
become males, and homogametic XX turn into hermaphrodites. Hermaphrodite 
worms maintain both X chromosomes active, but represses transcript levels from each 
X chromosome by half, to match the expression from the single X in males (Meyer 
and Casson 1986). Several of the proteins (MIX-1 and DPY-27) that comprise the 
dosage compensation complex in C. elegans are similar to the conserved 13S 
condensin complex, which is required for both mitotic and meiotic chromosome 
resolution and condensation (Meyer 2005). DCC members also perform double duty 
as members of canonical meiotic and mitotic condensin complexes, and play role in 
regulating the number and distribution of crossovers during meiosis. These studies 
provide a nice example of how the protein function can be generalized through 
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evolution, in this case, from constraining and resolving topological features of DNA 
to the regulation of gene expression. 
 
DCC in C. elegans is composed of at least eight proteins encoded by sdc-1, sdc-2, 
sdc-3, dpy-21, dpy-26, dpy-27, dpy-28 and mix-1 (Hodgkin and Brenner 1977; 
Hodgkin 1980; Meneely and Wood 1984; Meyer and Casson 1986; Meneely and 
Wood 1987; Villeneuve and Meyer 1987; Nusbaum and Meyer 1989; Plenefisch et al. 
1989; Lieb et al. 1998). Each one of the proteins is localized to both X chromosomes 
of hermaphrodites (Chuang et al. 1994; Chuang et al. 1996; Davis and Meyer 1997; 
Dawes et al. 1999). Mutations in the corresponding genes lead to XX-specific 
lethality with few exceptions: dpy-21 and sdc-1 are not essential for XX survival, and 
mix-1 is essential for both XX and XO animals, as MIX-1 is a shared subunit between 
the DCC and condensin complexes (Lieb et al. 1998; Hagstrom et al. 2002).  
 
DCC is recruited to the X specifically by the action of SDC-2 and DNA sequence. 
During sex determination, the ratio between X and autosomes (X:A) is sensed by a set 
of X signal elements (XSEs) and autosomal signal elements (ASEs), which regulate 
the expression of xol-1. In XX hermaphrodites, xol-1 is repressed, in XO males xol-1 
expression is induced, which in turn represses sdc-2. As a consequence, SDC-2 is 
present only in hermaphrodite embryos. It is the only protein of the DCC members 
that can recognize the X in the absence of all other DCC components (Nusbaum and 
Meyer 1989; Dawes et al. 1999; Chu et al. 2002). 
 
The DCC recognizes the X through a limited number of recruitment sites called rex 
(recruitment elements on X), and spreads from them afterwards (Csankovszki et al. 
2004; McDonel et al. 2006; Ercan et al. 2007). High-resolution ChIP mapping of 
DCC binding identified approximately 50 putative rex sites and a single 10 bp motif 
that encompasses information from previously identified motifs was found to be in 
common between them (Ercan et al. 2007). However, are not exclusive to the X, and 
not all the motifs on the X are bound by the DCC. The motif is more clustered on the 
X than other chromosomes, which suggests that the presence of multiple motifs 
provides a high-affinity binding site for the complex (McDonel et al. 2006; Ercan et 
al. 2007). DCC members are found preferentially bound near the transcription start 
sites, which implies that transcription initiation might be affected, although no 
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enzymatic function is known for the DCC members, except for the possible ATPase 
activity of DPY-27 and MIX-1 (Ercan et al. 2007). After the DCC has been targeted 
and spread, a repressed chromatin state is established over the chromosome, thereby 
maintaining the global, epigenetic regulation of X chromosomes that is maintained 
throughout the lifetime of hermaphrodites (Meyer 2005; Ercan and Lieb 2009).  
 
1.4.4. Dosage compensation in mammals 
 
Classically known and most studied process in mammalian dosage compensation is X 
inactivation in females: one of the two X chromosomes in females gets inactivated. 
This process can be divided into tree steps: (i) determination of the number of sex 
chromosomes followed by commitment to undergo dosage compensation; (ii) 
initiation of the inactivation process and spreading of silenced chromatin along the 
chromosome and (iii) maintaining the inactive state of the Xi (Avner and Heard 
2001). 
 
The initial steps in X inactivation are achieved by Xic, the X chromosome 
inactivation center. Prior to inactivation, determination of the number of X 
chromosomes relative to the cell ploidy has to be achieved, with only one X 
chromosome per cell eventually left functional. It is hypothesized that a blocking 
factor is produced in limiting amounts such that there is sufficient to bind only one 
Xic per diploid cell. The choice which of the two female X chromosomes will be 
inactivated depends on the tissue. In embryonic tissues, this choice is random, 
inactivated can be either paternal (Xp), or maternal (Xm) X chromosome. And in 
extraembryonic tissues it is always paternal X chromosome that gets silenced (Avner 
and Heard 2001). In consequence, in mammals, females have mosaic of X 
chromosome inactivation. 
 
Suppression of X chromosome expression is initiated at X inactivation center, a locus 
known as Xic in mouse and XIC in human that encodes the X inactive specific 
transcript, Xist (Morey et al. 2004). Xist is a polyadenylated, spliced non-coding RNA 
transcribed only from the inactive X chromosome, which it binds to and coats. This 
induces recruitment of Polycomb group proteins, Eed and Enhancer of Zeste, that 
maintain the selected X chromosome in an inactive state (Czermin et al. 2002; Muller 
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et al. 2002; Silva et al. 2003). The action of Xist produces an inactive state that is 
initially labile; however, additional epigenetic marks, such as methylation, act to 
permanently silence Xi activity (Plath et al. 2003). Later, additional heterochromatic 
marks appear on the Xi soon after: hypoacetylation of histone H4, methylation of 
H3K27, methylation of the CpG islands, incorporation of the histone variant 
macroH2a. Late replication timing is also conferred on Xi (Heard 2004). 
 
Interestingly, X inactivation has recently been found, in mice, during early pre-
implantation development, to be much more dynamic than previously thought. 
Paternally inherited X chromosome is initially inactivated in all cells of early 
embryos, but then is selectively reactivated in the subset of cells that will form the 
embryo, with random X inactivation occurring afterwards (Heard 2004). 
 
Dosage compensation in mammals, however, is not achieved by X inactivation only. 
Studies of single genes found that there are X-linked genes that escape the X 
inactivation. Thus, it was shown that X-linked in Mus spretus Clcn4 gene is expressed 
two-fold higher as compared with its autosomal ortholog in Mus susculus (Adler et al. 
1997). Recently, due to the development of microarray technique, it became possible 
to measure the average levels of X-linked and autosomal expressions. These studies 
demonstrate that the gene upregulation on the active X chromosome is involved in 
dosage compensation along with inactivation, and the upregulation of the single active 
X is independent of the process of X inactivation (Nguyen and Disteche 2006).  
 
In summary, mammals have developed two compensation mechanisms to counteract 
the imbalance of X-linked genes. Genes on the active X (Xa) chromosome are 
upregulated about twofold by a mechanism that still remains to be fully explained, 
resulting in a balance of X chromosome and autosomal expression in males. In 
females, upregulation of Xa expression is counteracted by inactivation of one of the 
two X chromosomes (Xi). This achieves a balance of X chromosome expression 
between sexes, although it remains unclear which of these mechanisms developed 
first, or if they co-evolved (Payer and Lee 2008). 
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1.4.5. Dosage compensation in Drosophila 
 
Drosophila melanogaster, often used as a model organism to dissect epigenetic 
regulation, provides another example of dosage compensation. The extensively 
characterized genetics of the fruit fly makes it possible to address many questions on 
the mechanisms of dosage compensation, and has provided an excellent model to 
study epigenetic regulation.  
 
Unlike in other organisms where dosage compensation is dependent on the restriction 
of X chromosome expression, the single X chromosome in heterogametic males is 
upregulated two fold, to achieve equal levels of transcripts in XY males and XX 
females. The X chromosome in males has no sequence difference to that of females, 
so males had to develop certain ways to a) make dosage compensation happen only in 
males and not in females, b) distinguish the X chromosome from autosomes, and c) 
maintain same level of gene expression compared to the other sex (Taipale and 
Akhtar 2005). 
 
Genetic screens in Drosophila directed to find male-specific lethal mutations 
identified several genes, collectively named MSLs, standing for male specific lethals 
(Bashaw and Baker 1997). They act together as a dosage compensation complex 
(Lucchesi 1998), which binds to multiple sites on the single male X chromosome and 
restores the level of gene transcripts to that of females. However, not all X 
chromosomal genes are dosage compensated (Ghosh et al. 1989; Baker et al. 1994; 
Kelley et al. 1995; Legube et al. 2006). One example of escape is the larval serum 
protein LSP1α. It is not compensated in males and consequently females have higher 
levels (Ghosh et al. 1989). Additionally, some genes are compensated in an MSL-
independent way. These genes are most likely compensated by Sex-lethal, the master 
sex-determining gene in Drosophila (Baker et al. 1994; Kelley et al. 1995; Cline and 
Meyer 1996). 
 
DCC includes 5 MSL proteins – MSL1, MSL2, MSL3, MLE (maleless), MOF 
(males-absent on the first) – and two non-coding RNAs, roX1 and roX2 (RNA on X) 
(Lucchesi 1998; Stuckenholz et al. 1999), and references therein; Fig. 4). The 
presence of this complex on the male X chromosome correlates with the occurrence 
 36 
of acetylated lysine 16 on histone H4 (Turner et al. 1992; Bone et al. 1994). H4K16 is 
a distinguishing feature of the male X chromosome in Drosophila. 
 
 
Figure 4. The dosage compensation complex contains five proteins (MSL1-3, MOF 
and MLE) and two non-coding RNAs (roX1 and roX2). The members of the complex 
are defined by their male specific lethality in respective mutant flies. An additional 
protein, Jil-1, is shown to interact with components of the DCC. 
 
MSL1, MSL2 and MSL3 are required for the DCC complex to associate with the X 
chromosome (Lucchesi 1998). They appear to mediate binding of the whole complex 
to chromatin, although none of these proteins contain a distinguishable DNA-binding 
domain (Kelley et al. 1995; Copps et al. 1998; Gu et al. 1998).  
 
MSL1 provides the assembly basis for the complex, as it interacts with all the other 
DCC members, except MLE (Scott et al. 2000). Interaction between MSL1 and MSL2 
occurs through amino-terminal leucine zipper like motif of MSL1 and the RING 
finger domain of MSL2 (Copps et al. 1998; Scott et al. 2000; Li et al. 2005). 
Carboxyl-terminus of MSL1 binds MOF with its PEHE domain, and further to the C-
terminus MSL1 binds to MSL3 (Scott et al. 2000; Morales et al. 2004).  
 
MSL2 protein has a RING finger domain and a cysteins rich motif at the C-terminus 
(Zhou et al. 1995). This RING domain has two zinc finger clusters and mutations in it 
result in disruption of interaction between MSL2 and MSL1 (Copps et al. 1998). It is 
through MSL2, that the DCC complex associates with the X chromosome, resulting in 
a very stable interaction between MSL2 and chromatin (Straub et al. 2005).  
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MSL3 has a C-terminus MRG domain, which is responsible for mediating the 
interaction with MSL1 (Morales et al. 2005). MRG domains are thought to be 
interaction platforms in large complexes that are usually chromatin related (Bowman 
et al., 2006). MSL3 belongs to a family of proteins that coevolved with the 
chromodomain-bearing HATs (Pannuti and Lucchesi 2000) and may have a function 
in spreading of the MSL complex over the X chromosome (Taipale and Akhtar 2005). 
MSL3 interacts with roX2 in immunoprecipitation experiments and is tethered to the 
X chromosome via RNA (Buscaino et al. 2003). It is also discovered in the same 
study that association of MSL3 with the X chromosome is sensitive to RNase 
treatment. MSL3 is regulated by acetylation by MOF as a consequence of a direct 
interaction between these proteins. The interaction of MSL3 with roX2 RNA, as well 
as localization to the X chromosome, are acetylation sensitive in vitro (Buscaino et al. 
2003). This findings show that MOF is important not only for acetylation of the X 
chromosome, but also for regulation of other DCC members. 
 
MOF is a histone acetyltransferase with specificity for lysine 16 acetylation on 
histone H4 (Akhtar and Becker 2001). It is an important enzymatic component of the 
dosage compensation complex and is discussed in the 3.2.1.1.1 part if this thesis.  
 
Another protein with enzymatic activity in the DCC is MLE. It has an ATP-
dependent RNA- and DNA-helicase activity in vitro, with the ATP-binding domain 
critical for its function in vivo (Lee et al. 1997). Most probably, however, that MLE 
functions in the DCC by altering the structure of the non-coding RNA, rather than by 
remodeling chromatin. Its localization to the X chromosome is RNAse sensitive, and 
the fact that MLE has a weak interaction with the rest of the DCC suggests that the 
binding may occur through roX RNAs (Richter et al. 1996; Copps et al. 1998). 
 
An additional protein, Jil-1, interacts with components of the DCC. While it does 
associate with all chromosomes in males and females, it is enhanced at the MSL 
binding sites in males (Jin et al. 2000) with enrichment dependent on the MSL 
complex. JIL-1 maintains chromatin in an open configuration in transcriptionally 
active regions in the genome through phosphorylation of histone H3 (Wang et al. 
2001). However, whether this protein plays a general or specific role in dosage 
compensation is not determined. 
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The DCC consists of not only proteins, but also of two noncoding RNAs, known as 
roX1 and roX2. These were discovered as male-specific RNAs in the adult brain 
(Amrein and Axel 1997; Meller et al. 1997). Although they differ in size (3.7 kb and 
0.5-1.4 kb) and sequence, their functions of targeting MSL complex to the male X 
chromosome are redundant. Most double mutants die with the very few males that do 
survive exhibiting profound mislocalization of their MSL complex, and binding to a 
number of ectopic autosomal sites are detected (Meller and Rattner 2002; Deng et al. 
2005). In contrast, males with a single roX knockout or mutation have no known 
phenotype (Meller et al. 1997; Meller and Rattner 2002). Overexpression of MSL1 
and MSL2 can partially compensate for the lack of either roX, through promoting the 
assembly of the MSL complex on the X chromosome and increasing viability of roX1 
roX2 mutant males. This suggests that proteins of the DCC have sufficient capacity to 
effect dosage compensation, and that roX RNAs enhance either complex assembly or 
localization (Oh et al. 2003).  
 
roX RNAs share a 30 nt similarity between themselves (Franke and Baker 1999). 
Deletion of it – along with another ~110 nt stretch of a similar sequence in the two 
RNAs (the DNAseI hypersensitive sites, DHS) – results in no obvious phenotype 
(Kageyama et al. 2001; Park et al. 2003; Stuckenholz et al. 2003). roX1 has a putative 
stem loop at the 3’ end, which might be responsible for roX1 functions, as deletions of 
other parts of the RNA of approximately 400 bases does not affect the rescue of male 
lethality by truncated RNAs in a roX- double-mutant background (Stuckenholz et al. 
2003). Experiments with roX2 give similar results: deletion of 17 nt from each of four 
regions with evolutionary conserved sequences and expressing the constructs in a roX- 
double-mutant background also does not affect the rescue of male lethality (Park et al. 
2008). However, it is shown that x-linked expression is reduced in roX- double mutant 
male larvae (Deng and Meller 2006). roX RNA functions might be maintained by 
their secondary structures, which so far have been difficult to be predicted 
computationally.  
 
 39 
1.4.6. Mechanism of dosage compensation  
 
1.4.6.1. Choosing the sex 
 
Prior to implementation of dosage compensation activity, the embryo must determine 
the ploidy of X chromosomes, in order to decide whether to implement dosage 
compensation or not. Failure to reach the correct decision results in lethality. In the 
fruit fly, sex determination, including estimating ploidy of sex chromosomes, occurs 
early in the development (Cline and Meyer 1996). 
 
Phenotypic sex is determined by the number of X chromosomes per nucleus: XX 
embryos are females, and XY are males. Unlike in mammals, the Y chromosome does 
not play role in phenotypic sex determination. The ratio between the number of X 
chromosomes and autosomes controls both sex determination and dosage 
compensation. It does so by regulating the master regulator of sexual differentiation, 
sex lethal (Sxl). Sxl is encoded on the X chromosome and is up-regulated by 
transcription factors transcribed from the X chromosome such that embryos with two 
X chromosomes initiate transcription from sxl promoter, and embryos with a single 
copy of X do not. This initial difference in sxl expression is further propagated by a 
positive feedback autoregulatory loop; Sxl protein self regulates its own mRNA 
splicing from the promoter that is constitutively expressed and in addition, Sxl 
regulates splicing of the transformer (tra) gene in a sex-specific manner, thus 
initiating phenotypic differentiation into females. Together with transformer2 (tra2), 
which is expressed in both sexes, tra directs the splicing of the doublesex (dsx) 
transcript, whose translated product represses male-specific genes, resulting in female 
sexual differentiation. In male embryos, the dsx transcript undergoes alternative 
splicing to result in a protein that represses female-specific genes, thereby inducing 
male sexual differentiation (Cline and Meyer 1996).  
 
Splicing of msl2 mRNA is under direct control of Sxl. Sxl-binding sites are located in 
both the 5’ and 3’ UTRs of the msl2 mRNA (Bashaw and Baker 1997; Kelley et al. 
1997). Normally, Sxl is present only in females, where it represses translation of the 
msl2 mRNA. Correspondingly, when Sxl is absent in females, dosage compensation is 
induced, resulting in the death of females. Conversely, ectopic expression of SXL in 
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males abrogates dosage compensation, resulting in the death of genetically 
determined males. Ectopic expression of MSL2 in females induces DCC assembly on 
both X chromosomes, indicating that all MSL components are induced and/or are 
stabilized by the presence of MSL2 (Duncan et al. 2006). 
 
1.4.6.2. Targeting the X  
 
MSL1 and MSL2 are the core components of the dosage compensation complex. Both 
are required for nucleation of DCC function, and depletion of them results in 
disassembly of the complex (Kelley et al. 1995; Zhou et al. 1995; Lyman et al. 1997). 
Other members of the complex are responsible for the subsequent activity of X 
chromosome inactivation. After targeting and assembly, the MSL complex spreads 
throughout chromatin. As a consequence of DCC spreading, histones of genes subject 
to dosage compensation become hyperacetylated at H4K16ac, which is linked to an 
increase in gene expression.  
 
Despite of many studies, the question of how the MSL complex distinguishes the X 
from the autosomes is still not answered. It is targeted to the X chromosome through 
trans-acting factors – roX RNAs, MSL1 and MSL2 – in conjunction with cis-acting 
DNA sequences. It was observed in mutants for MSL3, MLE or MOF flies, that 
MSL1 and MS3 are targeted to a limited number (35-100) of sites on the X 
chromosome, which have been named as chromatin entry sites (Lyman et al. 1997; 
Kelley et al. 1999). Not much is known about these sites; they function as nucleation 
sites, where the MSL complex enters and gets spread afterwards. Interestingly, roX1 
and roX2 genomic loci themselves are chromatin entry sites for the assembly of the 
DCC (Kelley et al. 1999; Meller et al. 2000) and this function is independent of their 
transcription (Kageyama et al. 2001; Park et al. 2003). The DCC initially assembles at 
over a hundred entry sites on the X chromosome, and thereafter, propagates over the 
entire chromosome to spread to all target genes. The spreading, however, rarely 
occurs from autosomal roX transgenes (Kelley et al. 1999), which implies that 
chromosomal context also plays an important role. It was also shown, that large X 
chromosomal translocations are able to recruit DCC complex even if they do not have 
a previously mapped entry site (Fagegaltier and Baker 2004; Oh et al. 2004). 
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Early observations were done on the polytene chromosomes, which can not provide 
high resolution. Development of chromatin immunoprecipitation technique (ChIP) 
made possible studying DCC binding to chromatin on a new level. Analysis of data 
from high resolution MSL1 and MSL3 binding profiles has not revealed any universal 
targeting sequence, although short degenerative sequences have been identified 
(Dahlsveen et al. 2006; Gilfillan et al. 2006), and it still remains unanswered if 
chromatin entry sites are restricted to a DNA sequence, or dependent on chromatin 
structure. In general, summarized data from ChIPs of MSLs show that despite of 
different immunoprecipitated proteins, cell types and embryonic stages, MSL share 
several similar features in their profiles (Alekseyenko et al. 2006; Gilfillan et al. 2006; 
Legube et al. 2006; Kind et al. 2008). Interestingly, not all genes on the X 
chromosome are bound by the DCC, however, there are few autosomal sites of clear 
binding (Alekseyenko et al. 2006; Gilfillan et al. 2006). In addition, there is no 
correlation found between the expression level and MSL abundance (Alekseyenko et 
al. 2006; Legube et al. 2006). Although many genes that are compensated are actively 
transcribed, transcription by itself does not explain the MSL binding. There are many 
genes that are bound by elongating form of RNA pol II and elongation factors, but are 
devoid of MSLs (Gilfillan et al. 2006; Legube et al. 2006). Another observation from 
these studies is the MSLs distribution on the genes: the MSLs’ profiles indicate an 
enrichment of proteins on the body and towards the end of the genes and affinity for 
targets correlates with their dosage compensation state (Gilfillan et al. 2006; Legube 
et al. 2006).  
 
MOF profile clearly stands out from those of other MSLs. First, MOF has binding 
targets throughout the whole genome in both males and females; second, it also shows 
a strong peak at promoters of bound genes. 3’ end enrichment of the genes on the X 
chromosome is MSL dependent, however promoter binding of both X chromosomal 
and autosomal genes is not (Kind et al. 2008). This finding suggests that MOF is 
involved in more general regulation at promoters in both sexes, and the MSL complex 
prolongs MOF’s functioning towards the 3’ end of the dosage compensated genes to 
up-regulate male X chromosome. Discovery of 3’ bias in binding of MSLs led to 
looking at positioning of known epigenetic marks. Thus, it was found that more than 
90% of MSL targets are enriched with H3K36me3 and it is a high correlation of 
MSLs and H3K36me3 position on the gene (Larschan et al. 2007).  
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It was recently shown in our lab, that ongoing transcription and polymerase passage 
through the gene is a prerequisite for target recognition, whereas the type of promoter 
and direction of transcription are not important (Kind and Akhtar 2007). Blocking of 
transcription by α-amanitin greatly reduces binding of the MSL complex to X 
chromosomal genes. However, transcription is not sufficient enough by itself as there 
are many genes on the X chromosome that are transcriptionally active, but not 
recognized by MSLs (Alekseyenko et al. 2006; Gilfillan et al. 2006; Legube et al. 
2006). Targeting occurs independently of the neighboring context, as it is shown that 
MSLs can be recruited on X-liked genes, translocated to autosomes. Most probably, 
the recruitment signal lies in the coding region of the gene, which is exposed during 
transcription. 
 
Recent work demonstrated that MOF is bound to promoters of numerous genes, that 
the distribution of MOF is not restricted to the maternal X chromosome and that MOF 
functions on all chromosomes in both sexes. However, how MOF is targeted to 
chromatin, the distribution of it over genes and the functional implications of 
association were not defined. The work presented in this thesis demonstrates that 
MOF is a constituent of a novel regulatory complex, termed NSL, that is targeted to 
the promoters of autosomal genes and that this NSL complex up-regulates expression 
of targeted genes.  
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2. AIMS AND OBJECTIVES 
 
 
Gene expression is a highly regulated, complex process that requires to overcome 
multiple levels of restriction to productively engage DNA dependent RNA 
polymerases (Woolfe and Elgar 2008). Whether a gene is expressed is dependent not 
only on the information content within DNA, but also on multiple epigenetic and 
regulatory effects acting on chromatin, the functional template upon which gene 
expression is regulated. These events are orchestrated by numerous proteins, which 
achieve a diverse range of events on the regulatory elements of gene promoters 
including alteration of the positional phasing of nucleosomes, substitution of variant 
histones, post-translational modification of nucleosomes and positioning of chromatin 
into specific nuclear locations.  
 
One attractive system to study the regulation of gene expression is dosage 
compensation in Drosophila. Dosage compensation ensures equal expression of X 
linked genes in males and females. In Drosophila, it is achieved by the MSL complex, 
which specifically recognizes the male X chromosome and doubles the expression of 
genes that require to be produced in equivalent levels in both sexes. Through the 
MOF acetyltransferase subunit, association of the MSL complex with the male X 
chromosome induces local acetylation of H4K16. This correlates with an increase in 
the expression of X linked genes, which the MSL complex fine tunes to two-fold 
higher than compared to females. 
 
Recently, enzymatically active MOF-containing complexes have been purified from 
Drosophila embryos, Schneider SF4 cells and from human HeLa cells expressing 
tagged constituents of MSL complex: MOF and MSL3 (Mendjan et al. 2006). Mass 
spectrometric analysis revealed a diverse spectrum of evolutionary conserved proteins 
associated with MSLs in flies and humans. These include components of the nuclear 
pore complex (Mtor, Nup153, Nup154, Nup160 and Nup98), the nuclear exosome 
(Dis3 and Rrp6) and chromatin-interacting proteins that are enriched at polytene 
chromosome interbands (Z4, Chromator and MBDR2) (Mendjan et al. 2006). In 
addition, four novel and uncharacterized proteins CG1135, CG4699, CG18041 and 
CG10081 were found in purification of TAP tagged MOF. CG1135 was named 
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dMCRS2 by the name of its human ortholog hMCRS2, and CG4699, CG18041 and 
CG10081 were named NSL1, NSL2 and NSL3 correspondingly, standing for non-
specific lethals, as P-element insertions in corresponding genes in Drosophila result in 
a general lethal phonotype. 
 
The aim of my PhD project was to functionally and biochemicaly characterize 
CG1135/MCRS2, a novel protein identified in MOF purification. In the course of this 
project it was found out that this protein is a member of a distinct complex which is 
composed of evolutionary conserved proteins. To characterize it and gain further 
insight into a functional role of this novel complex and MCRS2 in particular, multiple 
approaches were applied, including biochemical, cytological and genetic methods. 
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3. RESULTS 
 
 
3.1. Domain structure of MCRS2 
 
Drosophila MCRS2 protein is a novel poorly characterized protein composed of 578 
aa (63 kDa) (Fig.4). It has a fork-head associated (FHA) domain, which belongs to a 
class of signaling modules able to recognize phosphorylated epitopes on proteins 
(Hofmann and Bucher 1995; Yaffe and Smerdon 2001). This domain has been found 
in many regulatory proteins in eubacterial and eukaryotic genomes. They include 
kinases, phosphatases, kinesins, transcription factors, RNA-binding proteins and 
metabolic enzymes, which bind to phosphopeptides and take part in many different 
cellular processes, such as DNA repair, signal transduction and vesicular transport 
(Durocher et al. 2000). Mammalian homologues of Drosophila MCRS2, hMCRS1 
and its splice variant, have been reported to be involved in transforming, nucleolar 
sequestration, ribosomal gene regulation, signaling between telomere maintenance 
and cell-cycle regulation (Song et al. 2004; Wu et al. 2009). Recently, cDNA 
encoding residues 126-475 of hMCRS2 from the HeLa cell cDNA library has been 
found in yeast two-hybrid screening assay to identify Nrf1-interacting proteins (Nrf1 
[p45 nuclear factor-erythroid 2 (p45 NF-E2)-related factor 1] is a transcriptional 
activator), showing that hMCRS2 has a repression effect on Nrf1-mediated 
transcriptional activation (Wu et al. 2009). 
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human_MCRS1_isoform1 ---------MDK-------------DSQGLLDSSLMASGTASRSEDEESLAGQKRAS--- 35 
human_MCRS1_isoform2 ---------MTRGTGGTAQRGRSGPDSQGLLDSSLMASGTASRSEDEESLAGQKRAS--- 48 
mouse_MCRS1          ---------MDK-------------DSQGLLDSSLMASGTASRSEDEESLAGQKRAS--- 35 
drosophila_MCRS2     MEASRITAIASSAVSVTAPNPPTVSTIPTAAASTLIQVGVSPATTTMPTPAATTTTTTIG 60 
 
human_MCRS1_isoform1 ---SQALGTIP-----------------KRRSSSRFIKRKKFDDELVESSLAKSSTRAKG 75 
human_MCRS1_isoform2 ---SQALGTIP-----------------KRRSSSRFIKRKKFDDELVESSLAKSSTRAKG 88 
mouse_MCRS1          ---SQALGTIP-----------------KRRSSSRFIKRKKFDDELVESSLAKSSTRVKG 75 
drosophila_MCRS2     STASSAVGISTPIRNPISNLQIEQQNDQKRRSSSRTIKRKRFDDEIVEYNIAVPTNRSGT 120 
 
human_MCRS1_isoform1 ASGVEPGRCSGSE------------------PSSSEKKKVS-----------------KA 100 
human_MCRS1_isoform2 ASGVEPGRCSGSE------------------PSSSEKKKVS-----------------KA 113 
mouse_MCRS1          AGGVESGRCSGSE------------------PSSSEKKKVS-----------------KA 100 
drosophila_MCRS2     DANRSSRPRTTSQNYPALVGVPHTTLAPLNIPTSTPQTPLSVDSLLPGTPSTVASLSLAT 180 
 
human_MCRS1_isoform1 PSTPVPPS-PAPAPGLTKRVKKSKQP-------------------------------LQV 128 
human_MCRS1_isoform2 PSTPVPPS-PAPAPGLTKRVKKSKQP-------------------------------LQV 141 
mouse_MCRS1          PSTPVPPS-PAPTPGLTKRVKKSKQP-------------------------------LQV 128 
drosophila_MCRS2     PTTPAPLATPLPVAPIVTAVAHPKPPAMERSTTSERRSRPVRPASKKAQRRNGRPMGQMA 240 
 
human_MCRS1_isoform1 TKDLGRWKPADDLLLINAVLQTNDLTSVHLGVKFSCRFTLREVQERWYALLYDPVISKLA 188 
human_MCRS1_isoform2 TKDLGRWKPADDLLLINAVLQTNDLTSVHLGVKFSCRFTLREVQERWYALLYDPVISKLA 201 
mouse_MCRS1          TKDLGRWKPADDLLLINAVLQTNDLTSVHLGVKFSCRFTLREVQERWYALLYDPVISKLA 188 
drosophila_MCRS2     TKDLGRWKPIDDLALIIGIQQTNDLRIIHRGVKFSCKFTLQELQQRWYALLYEPAVSRIA 300 
 
human_MCRS1_isoform1 CQAMRQLHPEAIAAIQSKALFSKAEEQLLSKVGSTSQPTLETFQDLLHRHPDAFYLARTA 248 
human_MCRS1_isoform2 CQAMRQLHPEAIAAIQSKALFSKAEEQLLSKVGSTSQPTLETFQDLLHRHPDAFYLARTA 261 
mouse_MCRS1          CQAMRQLHPEAIAAIQSKALFSKAEEQLLSKVGSSSQPTLETFQDLLHTHPDAFYLARTA 248 
drosophila_MCRS2     VSAIRNLHPELVESVQRKALYSVQEEDLLGTIKSSEQPKLEQFQELLDKNASVFYCARTA 360 
 
human_MCRS1_isoform1 KALQAHWQLMKQYYLLEDQTVQPLPKGDQ-VLNFSDAEDLIDDSKLKDMRDEVLEHELMV 307 
human_MCRS1_isoform2 KALQAHWQLMKQYYLLEDQTVQPLPKGDQ-VLNFSDAEDLIDDSKLKDMRDEVLEHELMV 320 
mouse_MCRS1          KALQAHWQLMKQYYLLEDQTVQPLPKGDQ-VLNFSDAEDLIDDSKLKDMRDEVLEHELTV 307 
drosophila_MCRS2     KSLQNHWLLLKQYTLLPDQSVKPIYGTDQQPLSFSDAEDQIFEHDLNEPRDEALEMERAL 420 
 
human_MCRS1_isoform1 ADRRQKREIRQLEQELHKWQVLVDSITG-MSSPDFDNQTLAVLRGRMVRYLMRSREITLG 366 
human_MCRS1_isoform2 ADRRQKREIRQLEQELHKWQVLVDSITG-MSSPDFDNQTLAVLRGRMVRYLMRSREITLG 379 
mouse_MCRS1          ADRRQKREIRQLEQELHKWQVLVDSITG-MGSPDFDNQTLAVLRGRMVRYLMRSREITLG 366 
drosophila_MCRS2     ADRRNKRNIRLLENELSRWAVLVDSVLSPTAASEFDNQTLACLCGRHVRYLMRSKEITFG 480 
 
human_MCRS1_isoform1 RATKDNQIDVDLSLEGPAWKISRKQGVIKLKNNGDFFIANEGRRPIYIDGRPVLCGSKWR 426 
human_MCRS1_isoform2 RATKDNQIDVDLSLEGPAWKISRKQGVIKLKNNGDFFIANEGRRPIYIDGRPVLCGSKWR 439 
mouse_MCRS1          RATKDNQIDVDLSLEGPAWKISRKQGVIKLKNNGDFFIANEGRRPIYIDGRPVLCGSKWR 426 
drosophila_MCRS2     RDAKDCVVDVDLGLEGPAAKISRRQGTIKLRSNGDFFIANEGKRAIFIDGTPLLSANKAR 540 
 
human_MCRS1_isoform1 LSNNSVVEIASLRFVFLINQDLIALIRAEAAKITPQ-- 462 
human_MCRS1_isoform2 LSNNSVVEIASLRFVFLINQDLIALIRAEAAKITPQ-- 475 
mouse_MCRS1          LSNNSVVEIASLRFVFLINQDLIALIRAEAAKITPQ-- 462 
drosophila_MCRS2     LGHNCTVEISGLRFTFLVNYELINAIRQESAKTSNPLN 578 
 
Figure 4. Scheme of Drosophila MCRS2 and alignment of its homologues in human 
and mouse. Underlined residues are conserved amino acids in the FHA domain 
(Durocher and Jackson 2002). 
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3.2. Raising antibodies against MCRS2 
 
Overall, there was very limited information of published literature about this protein. 
As a first step towards characterization of the MCRS2 protein, polyclonal antibodies 
against 1-319 aa of MCRS2 protein were raised in rats and rabbits, in a project that 
was initiated by Anan Ragab and Herbert Holz in the lab. N-terminally GST tagged 
first 319 aa of MCRS2 protein were expressed in BL21 Rosetta (EMD Biosciences) 
using the pET41a vector system (EMD Biosciences). The protein was recovered from 
inclusion bodies and affinity purified on glutathione agarose (Fig. 5; for detailed 
information refer to Materials and Methods). This material was then mixed with Titre-
Max (Sigma) adjuvant and used to immunize 3 rats and 2 rabbits at three week 
intervals for a series of six injections.  
 
 
 
 
Figure 5. Purified, recombinant GST-tagged MCRS2, used for antibody production, 
loaded as 1, 2, 5, and 10 µl from the purification (lanes 4-7), compared to 0.5, 1 and 5 
µg of BSA (lanes 1-3). Calculated molecular weight of GST-MCRS2 is 61 kDa. 
Additional bands are representing degraded protein as well as unspecifically 
copurified proteins. 
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3.2.1. Rat αMCRS2 antibodies 
 
Pre- and post- immunization sera of rats were evaluated for specificity against 
Drosophila embryo nuclear extract and recombinant MCRS2. Western blot analysis 
(Fig. 6B) shows that immune sera of all three rats specifically recognize both 
recombinant GST-MCRS2 and the endogenous MCRS2 from Drosophila embryo 
nuclear extract. Incubation of membranes with preimmune sera results in a clean 
background (Fig. 6A); preimmune serum of the rat 2 shows in unspecific band above 
75 kDa in embryo nuclear extract, which is of a different size of the band recognized 
by immune sera. 
 
Figure 6. A. Western blots of Drosophila embryo nuclear extract (NE) and 
recombinant MCRS2 protein, probed with pre-immune from three rats. (*) indicates a 
nonspecific recognition of a band above 75 kDa in Drosophila embryos nuclear 
extract by the pre-immune serum of rat 2. B. Western blots of Drosophila embryo 
nuclear extract (NE) and recombinant MCRS2 protein, probed with immune sera from 
three rats. (**) shows a recognized band above MCRS2 size from a cytoplasmic 
contamination of a nuclear extract. Western blots were performed by Anan Ragab (A) 
and Herbert Holz (B). 
 
3.2.2. Rabbit αMCRS2 antibodies 
 
Similarly, pre- and post- immunization sera of rabbits were evaluated for specificity 
against Drosophila embryo nuclear extract and recombinant MCRS2. The rabbit α-
MCRS2 anti-sera (Fig. 7B) recognize specifically both recombinant GST-MCRS2 and 
the endogenous MCRS2 from Drosophila embryo nuclear extract. Unlike the anti-
sera, preimmune sera does not recognize specific proteins (Fig. 7A).  
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In conclusion, antibodies against MCRS2 were generated and characterized in three 
rats and two rabbits. All of them are able to specifically recognize MCRS2 in 
Drosophila embryo nuclear extract and can be used for multiple biochemical 
applications.  
 
At the same time, antibodies against a number of proteins, identified in MOF TAP 
purification, were raised in the lab, allowing further immunochemical characterization 
of MCRS2 and its potential interactors. 
 
 
 
 
Figure 7. Western blot of Drosophila embryo nuclear extract (NE) and recombinant 
MCRS2 protein, probed with (A) pre-immune sera from two rabbits – CDA and CCH; 
and (B) their corresponding post-immune sera.  
 
3.3. Immunoprecipitation analysis reveals biochemical partners of MCRS2 
 
MCRS2 was found as one of the proteins purified with TAP-tagged MOF. In order to 
address if the interaction of MCRS2 and MOF can be reproduced, an 
immunoprecipitation experiment using newly produced antibodies against MCRS2 
was performed. In addition to MOF antibodies, western blot membranes were probed 
with antibodies against proteins, which were found in the MOF TAP purification. 
Surprisingly, MSLs were not coimmonuprecipitated by MCRS2 (Fig. 8, lane 4). In 
order to compare MCRS2 interacting proteins to the MSL complex, an additional 
immunoprecipitation experiment using MSL1 antibodies was done and the membrane 
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was probed with the same set of antibodies (Fig. 8, lane 6). Again, none of the MSLs 
were found in the immunoprecipitate of MCRS2. Among other proteins, that were 
tested for the presence in MCRS2 immunoprecipitate, were Mtor and NXF1. Mtor has 
also been identified in the MOF TAP purification, however, immunoprecipitation 
with MCRS2 showed that it is not residing in one complex. NXF1 was used as a 
negative control protein, which was not present in MOF TAP purification. 
 
The experiment shows that MCRS2 coimmunoprecipitates MOF, NSL2, NSL3, WDS 
and MBDR2 in Drosophila embryo nuclear extracts, whereas MSL1 
coimmunoprecipitates only MSL3 and MOF (Fig. 8, lane 4 versus 6). These results 
indicated that MOF exists in two separate complexes: one complex is the MSL 
complex, and another one groups MCRS2 and NSLs. The experiment was performed 
together with Herbert Holz. 
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Figure 8. Western blot analysis of MOF interacting proteins. Immunoprecipitation 
was performed with MCRS2 and MSL1 antibodies using Drosophila embryos nuclear 
extract (lanes 4 and 6), corresponding pre-immune sera was used as a negative control 
(lanes 5 and 7), eluates were resolved by SDS-PAGE and probed with MCRS2, 
MBDR2, NSL3, NSL2, MOF, MSL1, MSL3, Mtor and NXF1 antibodies. 
 
 
3.4. Purification of a novel MCRS2 containing complex 
 
The results of coimmunoprecipitation experiment revealed a subgroup of proteins, 
distinct from the MSL complex, which were interacting with MOF. In order to 
identify all the interacting partners of MCRS2, tandem affinity purification of N-
terminally TAP-tagged MCRS2 was performed. To facilitate these analyses, a stable 
Drosophila SL2 cell line was established that expresses TAP-tagged MCRS2. The 
scheme of MCRS2 tandem affinity purification (TAP) is shown on figure 9. 
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Figure 9. A. Schematic representation of TAP-MCRS2 protein. MCRS2 is tagged 
with TAP tag, which consists of two units of protein A, separated by a TEV protease 
cleavage site from a calmodulin binding site. 
B. Sequential affinity purification of TAP MCRS2. The purification is performed 
under conditions that do not disrupt complexes containing the tagged protein. It is 
achieved by (1) retaining the TAP-tagged protein on IgG beads, washing non-binding 
proteins from the beads and then (2) releasing the complex from the beads by 
digestion with TEV protease. The resulting eluate is subjected to (3) a second round 
of purification on beads covalently coated with calmodulin. After (4) elution the 
resulting material is highly enriched in the TAP tagged protein and in the components 
of complexes containing the TAP tagged protein (adapted from (Puig et al. 2001)). 
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3.4.1. TAP-tagging of the MCRS2 protein and generation of stable 
Drosophila SL2 cell line 
 
The full-length open reading frame of MCRS2 protein was cloned into the multiple-
cloning site of the pBSactshort-N-TAP vector. Expression of the tagged protein is 
driven from a shortened Actin5C-promoter, which results in low-level ubiquitous 
expression of TAP tagged MCRS2. A stable Drosophila TAP-MCRS2 producing SL2 
cell line was established by co-transfecting the pBSactshort-N-TAP-MCRS2 
expression plasmid and the pUC-NEO resistance vector. Geneticin was used for the 
selection, with a range of concentrations between 0.8 and 1.2 mg/ml. Selection was 
monitored by the complete death of mock transfected cells and colony formation of 
stably expressing cells in cells transfected with the selection vector. Heterogeneous 
populations of transfected cells were then used to derive cell lines which were 
evaluated for MCRS2 expression (Fig. 10). For this, whole cell extracts from in the 
same amounts were loaded on a acrylamide gel and checked in western blot with PAP 
(anti-TAP) antibodies for the expression of the TAP tagged MCRS2. The result 
showed no difference in cell lines established either in 1.2 or 0.8 mg/ml of geneticin, 
the lower concentration of 0.8 mg/ml was used to establish and maintain stable cell 
line. Probing with antibodies against MCRS2 antibodies revealed a low level of 
expression of TAP-MCRS2 as compared to endogenous protein, as it can be hardly 
detected in the cell extract. This, however, precludes forcing the formation of aberrant 
complexes through over-expressing MCRS2 and is of a benefit. 
 
The expression of TAP-MCRS2 was checked in the whole cell extract. However, 
fractionation of cells into nuclear and cytoplasmic extracts (for the procedure, refer to 
Materials and Methods part of this thesis) indicated that MCRS2 is predominately 
present in the nucleus (Fig. 11, line 1 versus 2-3). It was therefore prudent to perform 
tandem affinity purification from nuclear extract preparations, thereby reducing 
contamination with cytoplasmic proteins. 
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Figure 10. Expression of endogenous and TAP-tagged MCRS2 under 1.2 and 0.8 
mg/ml of geneticin treatment in transfected SL2 cells, comparing to the wild type 
control (WT). Whole cell extracts from identical cell numbers (5x105) are loaded in 
each lane. Western blots were probed with peroxidase-anti-peroxidase (PAP, Sigma) 
diluted 1:2000 for detection of the protein A region within the TAP tag, and αMCRS2 
antibodies for detection of both endogenous and tagged MCRS2. TAP-MCRS2 is 
expressed in the stably transfected cell lines as shown on membranes probed with 
PAP antibodies, but at a low level as compared to endogenous MCRS2 and can be 
hardly detected. 
 
 
Figure 11. Nuclear localization of MCRS2. The presence of MCRS2 in nuclear 
(nuclear extract, NE) and cytoplasmic (cytoplasmic extract, CE) fractions was 
determined by western blotting. The blot was also probed for the cytoplasmic protein 
tubulin, to establish that fractionation had been achieved.  
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3.4.2. Optimization of the purification procedure  
 
Prior to isolating TAP tagged MCRS2 containing complexes from the stable cell line, 
conditions were established to determine that the procedures used to isolate the 
complex would function. Figure 9 shows the efficiency of TAP-MCRS2 binding to 
IgG beads. Nuclear extract from TAP-MCRS2 expressing cell line was incubated with 
IgG beads, after which washed beads were boiled in SDS loading buffer and 
supernatant loaded on a gel (Fig. 12, lanes 3 and 5). Nuclear extract from wild type 
SL2 cells was taken as a negative control and treated in the same way (Fig. 12, lanes 4 
and 6). The results show, that despite very low amount of TAP-MCRS2 in the starting 
material that prevents easy visualization of tagged protein, TAP-MCRS2 efficiently 
binds to IgG beads. 
 
 
Figure 12. IgG binding of TAP-MCRS2. The western blot is probed with αMCRS2 
antibodies. Because protein concentrations of starting materials of nuclear extract 
from TAP-MCRS2 cell line and wild type SL2 cells were not equalized, endogenous 
MCRS2 protein is not detected in the input of TAP-MCRS2 extract, but is present, 
however in very low amounts, in the supernatant after incubation of the extract with 
IgG beads due to the lager volume that was loaded (5% or the extract loaded as input, 
comparing to the 10% of the extract after incubation with IgG beads). TAP-MCRS2 is 
specifically enriched on IgG beads (100% of eluted from beads material is loaded). 
 
Next, the efficiency of TAP-MCRS2 binding to calmodulin beads was determined.  
Nuclear extract from TAP-MCRS2 expressing cells as well as from the wild type SL2 
cell line were incubated with calmodulin beads. Afterwards, beads were boiled in 
SDS loading buffer and 100% of material was loaded on an acrylamide gel (Fig. 13, 
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lanes 3-6), together with 10% of input (Fig. 13, lanes 1-2) and 10% of supernatant 
after incubation of calmodulin beads (Fig. 13, lanes 7-9). The binding of TAP-
MCRS2 to calmodulin was not very efficient and could not be increased by 
modifications to the protocol (changing salt concentrations in buffers, trying different 
amounts and batches of calmodulin beads), indicating that it would be necessary to 
start with a large amount of material to produce sufficient protein for determination of 
protein constituents of the complex by mass sequencing. 
 
 
Figure 13. Verification of the binding of TAP-MCRS2 to calmodulin beads. Western 
blot is performed with PAP antibodies. 10% of starting material from both extracts 
(TAP-MCRS2 cell line and a wild type SL2 cells) was loaded as an input sample. 
Washed calmodulin beads were boiled in SDS loading buffer and 100% of material 
was loaded. To check how much unbound to calmodulin beads TAP-MCRS2 is left in 
the nuclear extract from TAP-MCRS2 cell line, 10% of the supernatant after 
incubation with calmodulin beads was loaded as well. Experiment is done in duplicate 
with two different batches of calmodulin beads to find the one that is better in binding 
TAP-MCRS2. 
  
3.4.3. Biochemical purification of the NSL complex 
 
Proteins, associated with MCRS2, were isolated from nuclear extracts from the cell 
line, stably expressing TAP tagged MCRS2. For each TAP purification, 2x109 cells 
were required to prepare 1 ml of extract with approximately 6 µg/µl concentration of 
proteins. Nuclear extract from wild type SL2 cells was subject to the same procedure, 
and used as a mock control for TAP purification. Purified eluted material was run on a 
gel and silver stained (Fig. 14, lanes 3-4). Identification of proteins was done by 
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excision of specific to TAP MCRS2 purification bands (performed by Sven 
Fraterman, EMBL-Heidelberg), and by analysis of total complex elutions (Adrian 
Cohen, NCLMS, Netherlands). 
 
Mass spectrometric sequence analysis of eluted bands revealed that MCRS2 (bait) 
associates with NSL1, NSL2, NSL3, WDS and MBDR2 (Table 2). None of these 
proteins were present in material obtained from untagged control mock purification 
from wild type SL2 cells. Interestingly, all of these proteins were purified together 
with MOF (Mendjan et al. 2006), and there were no new proteins found in TAP 
MCRS2 purification.  
  
 
Figure 14. Silver stained gel of FLAG/HA purification of NSL1 (lanes 1-2) and TAP 
purification of MCRS2 (lanes 3-4); WT indicates corresponding mock purifications. 
1.5 ml of nuclear extract from each cell line is used with the concentration of 6 µg/µl, 
and 50% of the purified eluted material was loaded on a gel; the rest of the material 
was left for subsequent mass spectrometry analysis. 
 
At the same time, sequential FLAG/HA purification of nuclear extract from a stable 
cell line expressing TAP-FLAG-HA-NSL1 was performed in the lab by Philipp 
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Gebhardt. It also resulted in isolating the same set of proteins – NSL1 (bait), NSL2, 
NSL3, WDS, MCRS2 and MBDR2 – as well as MOF, Z4 and Chromator. Thus, the 
existence of the complex was confirmed by the purification performed of another 
tagged member of the complex. For the control, mock purification from nuclear 
extract of wild type SL2 cells was used (Fig. 14, lanes 1-2). 
 
Table 3. Proteins identified in TAP-MCRS2 purification. 
Name Acession 
number 
Mass 
[Da] 
Mascot score 
(Number of 
peptides) 
Number of 
experiments 
present  
(out of 6) 
Domains 
NSL1 gi|24647245 170587 48 (12) 4 coiled coil, PEHE 
NSL2 gi|23172607 57054 202 (3) 3 two C/H-rich domains 
NSL3 gi|17862340 114582 38 (12) 4 a/b hydrolase fold 
MCRS2 gi|16767858 63840 127 (5) 6 
forkhead-
associated domain 
(FHA) 
MBDR2 gi|45551883 120748 53 (8) 4 
CHAP1, 2 3 Tudor, 
MBD1, ZnF, PhD 
finger 
WDS gi|6946677 39530 241 (5)* 4 seven WD40 
repeats 
*number taken from another experiment 
 
3.4.4. NSL complex composition 
 
Results of purifications as well as those of immunoprecipitation show the existence of 
a novel complex composed of the evolutionary conserved proteins: MOF, NSL1, 
NSL2, NSL3, MCRS2, MBDR2, WDS, Z4 and Chromator. MSL proteins are not 
present in these purifications, indicating that they are not a part of the same complex. 
The new complex has been named the NSL complex, and the next section describes 
its members. 
 
NSL1 is a novel protein of 170 kDa, composed of 1570 aa. NSL1 has a putative coil-
coiled domain and a PEHE domain at its C-terminus. In Drosophila, the only other 
protein with a PEHE domain is MSL1 (Marin 2003). Just like MSL1, NSL1’s 
interaction with MOF might most probably be via the PEHE domain, as it was shown 
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to be true for human homologues: PEHE domain of hNSL1 interacted directly with 
hMOF in a GST pulldown (Mendjan et al. 2006). 
 
NSL2 is a novel protein of 127 kDa, composed of 1200 aa, that is evolutionary 
conserved from flies to humans. It is ubiquitously present in mice and in Xenopus 
laevis embryos from stage IV onwards (Shim et al. 2000; Mata et al. 2003). The 
protein has no pronounced domain structure, with sequence analysis only revealing an 
evolutionary conserved region that is rich in cysteine and histidine motif (Taipale and 
Akhtar 2005). 
 
NSL3 is a novel protein of 114 kDa, composed of 1066 aa. It contains an α/β-
hydrolase domain (Taipale and Akhtar 2005), this is one of the largest and oldest 
structural domain superfamilies that share a common fold and catalytic triad (Nardini 
and Dijkstra 1999). In NSL3, only the β-hydrolase common fold is retained; the 
catalytic triad is not. NSL3 may not have enzymatic activity, but could possibly retain 
the ability to recognize substrates. Additional functional and structural studies would 
be necessary to determine more conclusive answers. 
 
MBDR2 is a poorly characterized protein composed of 1081 aa (120 kDa). It contains 
DNA-binding, two Tudor and methyl binding (MBD) domains, as well as C2H2-type 
zinc-finger and a PHD finger (Taipale and Akhtar 2005). This suggests that MBDR2 
might have a spectrum of functions. MBD domains bind to methylated DNA and are 
involved in transcriptional repression in mammals (Bird 2002). In Drosophila, the 
function of DNA methylation is not clear as, in general, DNA methylation happens 
much more seldom than in mammals (Lyko et al. 2000). Tudor domains have been 
shown to bind methylated arginine residues in Sm proteins involved in splicing, and 
methylated H3K79 in yeast (Huyen et al. 2004). Tudor domains share similarity to 
chromodomains, which also can bind methylated residues (Lachner et al. 2001).  
 
WDS is the smallest protein in the complex, with only 361 amino acids (39 kDa). It is 
an evolutionary conserved protein, present from Arabidopsis thaliana to mammals. 
WDS belongs to the WD protein family and contains seven WD40 repeats (Hollmann 
et al. 2002). These repeats are modules involved in protein-protein interaction and are 
present in a variety of chromatin-associated complexes (Cao et al. 2002). The 
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mammalian ortholog, WDR5, binds specifically to dimethylated H3K4, and is also a 
constituent of H3K4-specific methyltransferase complexes (Wysocka et al. 2005). 
Methylated H3K4 in Drosophila, as well as in other organisms, is linked to 
transcriptional activation (Zhang and Reinberg 2001). Similar to MBDR2, the 
presence of WD40 repeats suggests possible functions of WDS in Drosophila, namely 
enhancing transcription from male X chromosome by bringing MOF to dosage 
compensated genes to induce local hyperacetylation and increase gene expression. 
WDS is ubiquitously expressed in Drosophila at all developmental stages and is 
essential for viability.  
 
Z4 is a 105 kDa protein of 996 aa. Z4 has 7 zinc-fingers, similar to the insulator 
binding protein CTCF, which is a protein involved in organizing chromosomal 
domains (Eggert et al. 2004). Z4 is essential for Drosophila development and acts in a 
dose-dependent manner on the development of several tissues. It is involved in 
chromosome compaction and higher-order chromatin structure formation (Eggert et 
al. 2004). Z4 mutant flies loose their band/interband pattern on chromosomes, with 
the interband chromatin exhibiting an overall decompaction of chromosomal material. 
Z4 mutants also have dose-dependent defects on position effect variegation. Z4 can be 
immunoprecipitated with Chromator, suggesting that that both proteins might be 
responsible for the chromosome higher-order structure during interphase (Eggert et al. 
2004). 
 
Chromator/Chris consists of 926 aa and has a molecular weight of 101 kDa. It is 
essential, and is ubiquitously expressed in Drosophila (Rath et al. 2004). Like MOF 
and MSL3, it also contains a chromodomain. Chromator localizes on polytene 
chromosomes together with the interband-binding protein Z4 (Gortchakov et al. 
2005). During mitosis, Chromator detaches from the chromosomes and aligns in a 
spindle-like structure. The C-terminal half of Chromator, lacking the chromodomain, 
is sufficient for both nuclear and spindle localization. Chromator is an essential 
protein; RNAi depletion of Chromator in SL2 cells induces abnormal microtubule 
spindle morphology and chromosome segregation defects (Rath et al. 2004). 
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3.5. NSL1 directly interacts with MCRS2 and MOF 
 
In order to dissect the interactions between the NSL proteins, baculovirus expression 
system was used. Constructs with tagged (FLAG or HA), as well as untagged NSL1, 
MCRS2 and MOF were expressed in baculovirus system. Copurification of the 
proteins revealed that stable interaction of NSL1 can be detected with MCRS2 and 
MOF (Fig. 15, lanes 1-2), which resists 200 mM salt. It showed that interaction 
between NSL1-MCRS2 and NSL1-MOF is direct and present between these proteins 
also when there are no other NSL complex members present. Interestingly, presence 
of a tag can influence the result of copurifications. Thus, by reciprocal tagging of 
MCRS2, NSL1 and MOF, it was observed that N-terminal tagging of NSL1 decreases 
the interaction of this protein with both MOF and MCRS2. This difference most 
probably comes from the sterical obstructions that tags bring to the proteins, 
preventing protein interactions.  
 
 
Figure 15. Reconstitution of NSLs interaction using baculovirus-expressed proteins. 
NSL1 interacts with (1) MCRS2 and (2) MOF upon incubation of protein extracts. 
After purification via corresponding tag, proteins were run on a gel and Coomassie 
stained. Experiment is performed by Herbert Holz.  
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3.6. NSLs bind to multiple sites on chromatin 
 
Next, the in vivo localization of NSLs was investigated by immunostaining salivary 
gland polytene chromosomes of Drosophila male and female larvae with antibodies 
directed against MCRS2, MBDR2 and NSL1. As it is shown on the figure 16, these 
proteins broadly decorate all chromosomes, comprising autosomes and sex 
chromosomes. Merge images show an overlap of the proteins with each other on 
many binding sites.  
 
 
 
Figure 16. Colocalization of MCRS2, MBDR2 and NSL1 on wild type male and 
female Drosophila 3rd instar larvae on polytene chromosomes. Confocal microscopy 
is performed on polythene chromosomes of 3rd instar wild type Drosophila larvae 
immunostained with MCRS2 MBDR2 and NSL1. DNA is visualized by Hoechst. 
 
The NSLs were found in the MOF TAP purification (Mendjan et al. 2006). In 
addition, immunoprecipitation experiments discussed above indicate interaction 
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between MOF and NSLs. NSL1 purification also resulted in identifying MOF in 
elutions. Genome-wide MOF profiling analysis carried in the lab (Kind et al. 2008) 
revealed many sites of MOF binding on autosomes. It was therefore interesting to see 
if NSL proteins coreside with MOF on same chromosomes. For this reason, 
immunostaining of Drosophila salivary gland polytene chromosomes with antibodies 
directed against MOF and MCRS2 was performed. As shown on the figure 14, it 
reveals many overlapping positions of both proteins on all chromosomes, with MOF 
being enriched on male X chromosome. 
 
In contrast to MSL complex, which localizes to the male X chromosome, the NSL 
proteins are widely binding all chromosomes in males and females. Immunostaining 
with MSL1 protein (Fig. 17), a member of the MSL complex, shows a specific 
recognition of the male X chromosome, and MCRS2 staining on male X does not 
completely overlap with that of MSL1, representing their presence in different 
complexes. 
 
Altogether, these data raise the possibility of an additional function of the MOF 
protein in Drosophila, independent of MSLs and, thus, dosage compensation, which it 
performs together with NSL complex. 
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Figure 17. Colocalization of MCRS2 and MOF on Drosophila 3rd instar larvae 
polytene chromosomes in males and females. As a control of a binding specificity, 
coimmunostaining of MCRS2 and MSL1 is shown. Confocal microscopy is 
performed on polytene chromosomes of 3rd instar wild type Drosophila larvae 
immunostained with MCRS2, MOF and MSL1, and additionally stained with Hoechst 
to visualize DNA.  
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3.7. The NSL complex binds to promoters of MOF target genes 
 
The immunostaining of polytene chromosomes presented above provides a global 
picture of NSL proteins binding on chromosomes. To gain a higher resolution of the 
binding sites of the complex on chromatin, a chromatin immunoprecipitation (ChIP) 
analysis was performed. Antibodies against MCRS2, MBDR2, NSL1 and MOF, in 
conjunction with their corresponding pre-immune sera serving to control the 
experiments, were used for ChIP experiments. 
 
For this analysis, chromatin was prepared from 3rd instar larva glands from 
Drosophila wild type male and was used for the consistency of results obtained from 
the immunostainings. Besides, it was interesting to see the binding profile of the NSL 
complex in the differentiated tissue. Sheered formaldehyde cross-linked chromatin 
gave fragments ranging in size from several thousand bp to tens of bp, with a small 
peak at 200 bp (Fig. 18, A; for a detailed protocol of chromatin preparation and 
chromatin immunoprecipitation see Materials and Methods). To immunoaffinity 
isolate chromatin associated with particular components, sheared chromatin was 
incubated with antibodies of interest or with their corresponding pre-immune sera, 
immunocomplexes were recovered on protein A/G sepharose beads and DNA was 
then purified. Quantitative PCR on Gprk2, a gene discovered through whole genome 
analysis of sites bound by MOF (Kind et al. 2008), was used to determine the 
proportion of material that could be recovered by immunoaffinity purification (Fig. 
18, B). Primers were designed to probe the occupancy of MOF, NSL1 and MCRS2 on 
the promoter region, body of the gene and 3’ end of the coding sequence. The reason 
for such a combination of primers comes from the studies in the lab, where it was 
shown that MOF has a bimodal distribution on the genes where it is bound to. On X-
linked genes MOF is present through out the gene with two peaks: on promoter and 3’ 
end. On autosomal genes MOF binds only to promoters. It was interesting to compare 
profiles of NSLs binding with that of MOF. As a result of the experiment, NSL 
complex proteins were observed specifically bound to promoter of Gprk2 gene, with a 
high percentage of input recovery.  
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Figure 18. (A) Chromatin isolated from salivary glands. Formaldehyde crosslinked 
chromatin was sheared, the crosslinking reversed and the resulting material was 
treated with RNAse A and proteinase K prior to separation on a 0.8% agarose gel. (B) 
Chromatin immunoprecipitation performed on Drosophila wild type male larva 
glands using MOF, NSL1 and MCRS2 antibodies with respective preimmune sera. 
The quantity of purified DNA was determined by real time qPCR with three primer 
pairs spanning the promoter, middle and end of the Gprk2 gene. Results are presented 
as a percentage of input material used (primer sequences are listed in Materials and 
Methods). 
 
In parallel, same set of experiments was performed with the chromatin from SL2 cell 
line, as it was interesting to see if there are differences in NSL binding profile in 
undifferentiated cells of embryonic origin. In conclusion, same profile was observed 
for the NSL binding between salivary glands and SL2 cells, and it was found out that 
the proteins were present on the promoter region of MOF-bound genes, as shown on 
the figure 19 on the example of Gprk2 gene. However, chromatin from salivary 
glands gave much higher levels of recovery, it was therefore decided that further ChIP 
experiments would be performed only with chromatin from larval salivary glands. 
 
Having the material and established the conditions for ChIP, more genes were 
checked for the presence of the NSL complex. The location in relation to gene 
structure was determined using qPCR to scan the proximal promoter, gene body and 
3’ end of transcripts. Genes known to be bound by MOF were chosen as primary 
targets, on the X chromosome and on autosomes, according to ChIP-chip data 
produced in our lab (Kind et al. 2008). For negative controls, genes not bound by 
MOF genes were also characterized (Table 4).  
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Figure 19. (A) Chromatin isolated from SL2 cells. Formaldehyde crosslinked 
chromatin was sheared, the crosslinking reversed and the resulting material was 
treated with RNAse A and proteinase K prior to separation on a 0.8% agarose gel. (B) 
Chromatin immunoprecipitation performed on male larva glands of Drosophila wild 
type using MOF, NSL1 and MCRS2 antibodies with respective preimmune sera. The 
quantity of purified DNA was determined by real time qPCR with three primer pairs 
spanning the promoter, middle and end of the Gprk2 gene. 
 
Table 4. MOF-bound and not-bound genes looked at NSL complex localization. 
Genes bound by MOF 
X chromosomal Autosomal 
X chromosomal genes 
not bound by MOF 
CG6506 CG4245 CG6398 
CG4406 CG9536 OdsH 
CG32560 Sec5 Runt 
Dspt6  HBS1  
Rb NSL3  
roX2 Gprk2  
 
The results of qPCR performed on ChIP purified material are summarized in the 
Figure 20. The data presented is an average of five experiments that used five 
independently prepared chromatin samples. It shows that, within this restricted data 
set, MOF associates over the entire transcribed region of X chromosomal genes, but is 
present only at promoter regions of autosomal genes, as previously described (Kind et 
al. 2008). NSL1, MCRS2 and MBDR2 are present on the same genes as MOF; 
however, in contrast to the profile of MOF on the X chromosome, they recognize only 
promoter regions, independently of the chromosomal location of the gene. 
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Figure 20. ChIP analysis from larval salivary glands using antibodies against MOF, 
NSL1, MCRS2 and MBDR2. Preimmune sera is used as a negative control for each 
antibody. Immunoprecipitated DNA was amplified by real-time PCR with primer sets 
indicated in the material and methods. Each gene is evaluated at promoter region, 
middle of the transcribed sequence and at the 3’ end. Percent input is determined as 
the amount of immunoprecipitated DNA relative to input DNA. The data presented is 
an average result from five biologically independent experiments. The standard 
deviations of the replicate results are shown as error bars. 
 
The ChIP analyses performed on these selected genes is limited, as firstly requiring 
prior knowledge of which genes are targeted by particular complex, and secondly, 
only a limited number of genes can be characterized by real-time quantitative-PCR. 
To see if the promoter binding is a general phenomenon, the comprehensive, genome-
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wide determination of binding sites for the NSL complex will be obtained massively 
parallel sequencing of DNA enriched for association with NSL components (ChIP-
seq). This work is in progress.  
 
3.8. NSLs and transcription regulation 
 
Results of ChIP with MCRS2, MBDR2 and NSL1 revealed that NSL complex 
members are localized on promoters of autosomal and sex chromosomes. In addition, 
the polytene chromosome staining suggests that there are plenty of sites on the 
genome where they bind on both X and autosomes. One of the most obvious 
questions that arise is whether the NSL complex is involved in the regulation of gene 
expression. To address this question, fly lines expressing RNAi were used. In 
collaboration with Sunil Jayaramaiah Raja, using RNAi mediated depletion of 
MCRS2, MBDR2 and NSL3 in salivary glands, it was shown that expression of many 
target genes is affected by depletion of the NSL components and that, as anticipated, 
expression is downregulated when the NSL complex is compromised (Fig. 21). 
 
Several genes, based on the MOF presence, as well as chromosomal location, were 
used in this study. Two groups of genes were chosen on the X chromosome: MOF 
bound Ucp4a, Dspt6, Par6, RB, CG2967, CG6506, and CG4406; not bound by MOF 
CG14788 and CG12065. Similarly, two groups of autosomal genes were chosen: 
MOF bound Gprk2, CG9536, Sec5, PI3K92E, Eyg, NSL1, NSL2, NSL3 and MCRS2; 
not bound by MOF – MBDR2 and Nrv2. The efficiency of knock down was around 
80% for MCRS2, MBDR2 and NSL3, as shown on the figure 20. It was found, that 
irrespectively of the gene location and the gender, expression of MOF bound genes is 
downregulated more than two fold upon RNAi knockdown of the NSL components 
comparing to the control. Interestingly, the experiment also shows that expression of 
NSL proteins themselves is effected by the knock down of each other.  
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Figure 21. Expression analysis of X chromosomal (Ucp4a – CG12065) and 
autosomal (Gprk2 – NSL2) genes upon MCRS2, MBDR2 and NSL3 knock down in 
salivary glands, in male and female Drosophila 3rd instar larvae. CG14788 and 
CG12065 are autosomal genes not bound by MOF; MBDR2 and Nrv2 – X 
chromosomal not bound by MOF genes. Expression of many MOF target genes is 
downregulated more than two fold upon RNAi knockdown of the NSL components 
comparing to the control. 
 
These results suggest that the NSL complex members act as transcriptional co-
activators on MOF target genes. Upon depletion of MCRS2, MBDR2 or NSL3 
components of the NSL complex, the expression levels of many X chromosomal as 
well as autosomal genes in both males and females are reduced. The complex is 
involved in regulation of a wide number of genes and its effect is likely to be more 
general than the MSL complex, whose activity is restricted to the male X-
chromosome. 
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3.9. NSLs affect each other’s stability 
 
Decreased RNA levels of the NSLs upon MCRS2 knock down were then compared to 
the protein levels of the respected genes. For this, RNAi mediated knock-down of 
MCRS2 in SL2 cells was performed and the level of knock down was checked in 
Western blot by probing membranes with MCRS2 antibodies. MCRS2 knock down 
was compared to the EGFP knock down. As shown on the figure 22, the efficiency of 
the MCRS2 knock down is around 90%. Analysis of the cellular levels of MBDR2, 
Z4, Chromator, MOF and WDS by western blot determined that these components of 
the NSL complex are reduced when MCRS2 is depleted; cellular levels of tubulin are 
unaltered by RNAi treatment (Fig. 22). Additional analysis of other members of the 
NSL complex in the MCRS2 knock down on (data not shown) shows that among 
other effected proteins are NSL2 and NSL3. 
 
 
Figure 22. RNAi mediated depletion of MCRS2 reduces the intracellular level of 
other components of the NSL complex. SL2 cells are treated with EGFP or MCRS2 
dsRNA with components of the NSL complex then analyzed by western blot. Tubulin 
is used as a control protein whose stability should not be affected by siRNA 
treatment.  
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To show that effect of MCRS2 knock down is specific to the NSLs, it was compared 
to the one of MSL1. As shown on figure 23, the efficiency of MCRS2 knock downs 
was around 80%, while the one of the MSL1 was almost complete. Probing same 
membranes with MBDR2 antibodies, it was shown that the effect of MCRS2 knock 
down is specific to the NSL complex, as indicated by decreased levels of the MBDR2 
protein, and it does not influence protein levels of MSL1. MSL1 protein levels stay 
unchanged upon MCRS2 knock down; reciprocally, MCRS2 protein level is also not 
affected in the MSL1 knock down cells (Fig. 23).  
 
 
 
Figure 23. RNAi mediated reduction in MSL1 and MCRS2 does not influence each 
others protein levels, suggesting that MSL and NSL complexes operate independently 
of each other. Control cells are treated with EGFP dsRNA. Tubulin is used as a 
control protein, unaffected by siRNA treatment. 
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4. DISCUSSION 
 
In Drosophila, dosage compensation is achieved by the MSL complex, composed of 
the MSL1, MSL2, MSL3, MOF and MLE proteins together with noncoding RNAs – 
roX1 and roX2. It achieves dosage compensation by specifically binding to the male 
X chromosome and inducing global hyperacetylation of H4K16, which is associated 
with transcriptional activation. Recently, a connection between the dosage 
compensation complex and a new group of proteins was found through purification of 
MOF containing complexes, isolated from Drosophila embryos, a Drosophila cell 
line and a human cell line (Mendjan et al. 2006). Within the same study, isolation of 
MSL3 co-purified a similar set of interaction partners, although several proteins 
identified in the MOF purification were not found when MSL3 was used as bait. The 
interconnection between proteins classically believed to be involved only in dosage 
compensation with the range of nuclear and transcriptional processes was reinforced 
by the observed evolutionary conservation of complex components between fly and 
human, despite differing mechanisms of achieving dosage compensation in these 
organisms. Collectively, the functional connections between MOF and a large set of 
proteins suggest that it has functional roles in gene regulation beyond dosage 
compensation.  
 
4.1. Purification of a novel complex, termed the NSL complex 
 
Several proteins that purify with MOF, but not with MSL3, had not been previously 
characterized, those include MCRS2, NSL1, NSL2 and NSL3. Immunoaffinity 
purification of MCRS2 co-precipitated MOF, MBDR2, NSL2 and NSL3 from nuclear 
extracts, whereas no interaction of MCRS2 with MSL1 or MSL3 was detected. It 
suggested that there are different complexes where MOF is residing. Tandem affinity 
purification MCRS2 showed that, indeed, there is a novel complex consisting of 
several proteins, namely NSL1, NSL2, NSL3, MBDR2 and WDS, in addition to 
MCRS2. All of these proteins had been previously identified in purification with 
MOF. Surprisingly, no MSL constituents, apart from MOF, were co-isolated with 
MCRS2. Parallel purification of NSL1 revealed a complex with the same components 
as when MCRS2 was used as bait, although, in addition, MOF, Chromator and Z4 
proteins were also co-purified. Chromator and Z4 were already known to co-purify 
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with MOF. Collectively, the data from complexes defined by purifications of MCRS2 
and NSL1 show that a distinct complex exists. This novel assembly of proteins, the 
NSL complex, contains MOF, NSL1, NSL2, NSL3, MCRS2, MBDR2, WDS, Z4 and 
Chromator. The connection of MOF with another complex suggests that it has 
additional functions beyond dosage compensation. 
 
Experiments to directly probe interactions between NSL complex members, using 
baculovirus-expression, showed that NSL1 copurified with MOF and MCRS2 in the 
absence of other complex members. This suggested that the interaction between these 
proteins is specific and direct. In addition, MCRS2 was found previously in our lab, 
by yeast two-hybrid technology, to interact with MOF, again indicating a direct 
interaction between MCRS2 and MOF. 
 
4.2. Similarities between the MSL and NSL complexes 
 
An interesting similarity between the MSL and NSL complexes is that both of them 
have a component with a rare PEHE domain in their structure: these are the NSL1 and 
MSL1 proteins. They are the only two proteins in Drosophila that have this domain, 
and it is shown, that interaction of them with MOF occurs though this domain. 
 
To address the functional significance of the MCRS2 protein, studies of the complex 
in conditions of depleted MCRS2 were carried out. It was found, that upon RNAi 
mediated knock down of MCRS2 in SL2 cells, protein levels of MCRS2, MBDR2, 
Z4, Chromator, NSL2 and NSL3 are decreased. These results suggest 
interdependency between protein components of the NSL complex, which is reflected 
in their stability. Depletion of MCRS2 severely affects the amount and localization of 
other NSL complex members, indicating that MCRS2 might be a central component 
of the NSL complex, perhaps through nucleating complex assembly.  
 
Interestingly, MCRS2 exhibits a similar effect on the NSL complex, as MSL2 has on 
the MSL complex. MSL2 is a crucial component of the MSL complex. It is present 
only in males, as in females translation of msl2 mRNA is inhibited (Kelley et al. 
1997; Gebauer et al. 2003; Grskovic et al. 2003; Beckmann et al. 2005). Without this 
protein, the dosage compensation complex is not assembled. The mechanism of the 
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effect of MCRS2 on the NSL complex still needs to be discovered. It could be that 
MCRS2 is involved in controlling the expression of other NSLs, or it provides a 
platform for the complex assembly, or there are other mechanisms that we still do not 
know.  
 
4.3. NSL complex colocalizes with MOF on chromatin 
 
Staining of polytene chromosomes shows that MSL proteins bind multiple sites on the 
male X chromosome and colocalize with MOF. However, the MOF staining pattern is 
slightly different: while being enriches on the male X chromosome, MOF has a broad 
distribution over all chromosomes in both sexes (Kind et al, 2008). These data 
suggested that MOF has an additional function, apart from the dosage compensation. 
Immunostaining of polytene chromosomes with antibodies against NSL complex 
members indicated that NSLs bind to all chromosomes in a broad pattern both in 
males and female. Interestingly, the chromosomal staining patterns of the NSLs 
overlap at many sites with that of MOF on X chromosome, as well as on all 
autosomes both in males and females. 
 
The staining of the chromosome squashes provided valuable information concerning 
the localization of the NSL proteins towards MOF. In order to gain resolution of NSL 
binding sites at the level of individual transcriptional units, chromatin 
immunoprecipitation experiments using antibodies against the NSL proteins and MOF 
were performed. To do so, a set of MOF bound genes, provided by the MOF profiling 
done in the lab (Kind et al. 2008), was used. ChIPs performed to determine the 
binding of NSL1, MCRS2, MBDR2 and MOF show an association of these proteins 
with promoters of MOF bound genes. In addition, MOF binds the 3’ end of the X 
chromosomal genes. Other data from the lab have shown that the binding of MOF at 
the 3’ end of the genes correlates with the MSL binding. NSL colocalize with MOF at 
promoter regions and is absent from the 3’ end, emphasizing that MOF function with 
NSL is independent of MSL.  
 
Subsequent comprehensive, genome-wide determination of binding sites of the NSL 
complex will be obtained by massively parallel sequencing of immunoaffinity 
purified DNA using antibodies against NSL components (ChIP-seq). As NSLs are 
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present on genes where MOF is bound, and that MOF associated with a considerable 
number of genes, it is likely that a strong correlation, indicated by overlapping 
regions, will occur between MOF and NSL targets on chromatin.  
 
Preliminary experiments from our lab indicate that binding of MOF binding is 
reduced upon RNAi mediated depletion of MCSR2. This result is very interesting as it 
shows that the NSL complex contributse towards targeting MOF to target gene 
promoters. Our lab has previously shown (Kind et al. 2008) that H4K16 acetylation is 
downregulated upon the reduction of MOF. It would be therefore interesting to test 
whether the level of H4K16ac mark on target genes is affected in NSLs knock down 
cells. Reduced level of this mark could be an explanation for the downregulation of 
expression of MOF bound genes, as H4K16ac is linked to an increased rate of 
transcription. These experiments are currently underway. 
 
4.4. NSL complex is involved in transcription regulation 
 
The fact that NSLs are localized on the promoters of many genes prompted an 
evaluation of the transcriptional changes of genes subject to regulation by NSL. To 
address this question, total RNA from the salivary glands of fly lines specifically 
expressing RNAi targeting NSL components in salivary glands were isolated and 
subject to reverse transcription with subsequent real-time quantitative analysis by 
qPCR using gene-specific primers. The depletion of NSL components results in a 
strong decrease in transcription of NSL-bound genes in males and females, on 
autosomes as well as on the X chromosome. The expression levels of non-bound 
genes are not reduced, indicating that this decrease is a direct effect of the absence of 
the NSLs. Altogether, these data strongly suggest that the NSL complex functions 
generally as an activator of transcription. The broad polytene chromosome staining of 
NSLs implies that many chromatin regions are occupied by the NSL complex, which 
is likely to be involved in regulation of a wide spectrum of genes. A better 
understanding of the proportion of genes regulated by the NSLs and their nature will 
be derived by genome-wide profiling of binding sites of the NSL complex members 
in comparison with expression data, derived either from expression arrays or by 
massively parallel sequencing. Comparison of the data from wild type and MOF and 
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NSLs mutants will facilitate the understanding of the involvement of these complexes 
in the global regulation of gene expression in Drosophila. 
 
4.5. Mechanism of targeting to promoters 
 
An important question to answer is how the NSL complex is targeted to responsive 
promoters. One alternative is that the complex is directly binding the chromatin. 
Among the NSLs there are several proteins, which can be potentially involved in 
targeting the complex. One of the proteins, which may be involved in targeting the 
NSL complex to promoters, is MBDR2. MBDR2 has several interesting domains, 
among which are Tudor and methyl binding (MBD) domains, (Taipale et al. 2005). 
Tudor domains share similarity to chromodomains, which also bind methylated 
residues (Lachner et al. 2001). In yeast, Tudor domains have been shown to bind 
methylated H3K79 (Huyen et al. 2004). MBD domains bind to methylated DNA and 
are involved in transcriptional repression in mammals (Bird 2002). In Drosophila, 
however, DNA methylation happens much more seldom than in mammals and the 
function of it is not very clear (Lyko et al. 2000). MBDR2 has however the potential 
to recognize modified chromatin and target the NSL complex to it. 
 
Another protein with a potential of binding to chromatin is WDS. It belongs to the 
WD family and contains seven WD40 repeats (Hollmann et al. 2002). It is known, 
that these repeats are involved in protein-protein interaction and are present in many 
chromatin-associated complexes (Cao et al. 2002). The mammalian ortholog of this 
protein, WDR5, binds specifically to dimethylated H3K4 and also is a constituent of 
H3K4-specific methyltrasnferase complexes (Wysocka et al. 2005). Methylated H3K4 
is associated to transcription activation (Zhang and Reinberg 2001). Therefore, WDS 
can be potentially one of the proteins in the NSL complex that specifically recognizes 
H3K4 methylated chromatin of promoters and brings the complex to regulate 
transcription of the target genes by, for example, bringing MOF to induce local 
hyperacetylation and increase gene expression. 
 
It was proposed, that the MSL complex recognizes some degenerate sequences at 3’ 
end of genes, which leads to the binding of it to the chromatin.  It would be interesting 
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to know, if there is a similar kind of a sequence that the NSL complex is recognizing 
at the promoter regions, with a subsequent binding to it. 
 
Another alternative is that the NSL complex can be brought to promoters not only by 
direct binding of its members with chromatin, but through an interaction with 
components of transcription machinery or with regulatory proteins present on 
promoters. These interactions are most probably transient, and reflecting an inherent 
instability, no such proteins have been purified with the NSL complex. An interesting 
issue is a possible interdependency between MOF and NSLs in binding to chromatin. 
From the MSLs studies it is known that, although MOF binding is compromised on 
the body of genes upon MSL1 knock down, the association of MOF to promoters is 
not affected in these conditions (Kind et al. 2008). This suggests that binding of MOF 
to promoters is independent of MSL. It would be interesting to investigate whether 
MOF binding to promoters is also independent of the NSL complex, or MOF requires 
an assistance of the NSL complex to associate with promoter regions. For this, ChIP 
with NSLs antibodies using chromatin derived from NSLs and MOF mutant flies or 
from MOF RNAi mediated knock down cells will provide an answer.  
 
4.6. The model of the MSL and NSL complexes function  
 
Dosage compensated genes are upregulated through the action of histone acetylase 
activity of MOF within the MSL complex. Consequently, genes associated with MSL 
have local hyperacetylation of H4K16, which promotes gene expression. Components 
of the MSL complex bind all over the coding sequence of compensated genes, 
peaking at 3’ end. MSL1 and MSL2 recognize 3’ regions of target genes probably 
through degenerate sequence elements (Dahlsveen et al. 2006; Gilfillan et al. 2006; 
Kind and Akhtar 2007). This leads to the recruitment of MSL3, which stabilizes the 
MSL1/MSL2/chromatin interaction. Binding of MSL3 to H3K36me3 might be an 
event that brings MOF to the body if the gene (Larschan et al. 2007). However, in 
contrast to other components of the MSL complex, MOF is also present on the 
proximal promoter region of genes, on all chromosomes and in both males and 
females. This binding is independent of the MSL complex (Kind et al. 2008). The 
profile of H4K16ac correlates with the binding of MOF on autosomes and on the X 
chromosome. On the X chromosomal genes, H4K16ac peaks at the 3’ end of genes 
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(Kind et al. 2008). The work presented in this thesis shows that the NSL complex 
coresides with MOF specifically at the promoters of many genes (Fig. 22). Since the 
depletion of the NSL proteins resulted in the down regulation of target genes, the NSL 
complex might likely be implicated in the gene activation of the tested genes. An 
open question is whether this gene regulation is direct effect of the MOF acetylation, 
or is the result of the function of the NSL proteins. To answer this question, the 
binding of MOF in the NLS proteins knock down background and vice versa has been 
investigated. However, the efficiency of the knock down was not enough to provide a 
clear answer, and this work is still in progress.  
 
 
Figure 22. The differential distribution of the NSL and MSL complexes on genes. 
The NSL complex, in association with MOF, recognizes gene promoters and binds 
them. This induces H4K16 acetylation of proximal promoter regions, thereby 
increasing the transcriptional potential of the gene. On the male X chromosome, the 
NSL complex works in conjunction with the MSL complex, which then spreads itself 
and MOF over the body of the gene, thereby provoking general acetylation of male X 
chromatin. This correlates with an increase of transcription from the male X 
chromosome and results in dosage compensation.  
 
4.7. Evolution conservation of the NSL proteins 
 
Interestingly, the NSL proteins are conserved between two very evolutionary distant 
organisms: fly and human. First experiments showed that they might also reside in 
one complex together in human cells, as they segregate in the same fractions of a 
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nuclear extract after gradient centrifugation (Mendjan et al., 2006). This conservation 
indicates that NSLs are important for cell function. Although they have been 
identified in the dosage compensation studies, they are involved in general 
transcriptional regulation, in addition to X chromosomal genes dosage compensation. 
Correspondingly, in man, hMOF is linked with cancer. In normal human cells, about 
60% of total histone H4 is monoacetylated, mostly at lysine 16, while this acetylation 
is frequently lost in cancer (Munks et al. 1991). hMOF is responsible for the specific 
acetylation of H4K16 and its depletion leads to global reduction of H4K16ac in HeLa 
cells (Taipale et al. 2005). In addition, hMOF depleted cells have an impaired DNA 
repair response following ionizing radiation (Taipale et al. 2005). hMOF is 
responsible not only for H4K16 acetylation, but is also able to acetylate the tumor 
suppressor protein p53, and this modification of p53 mediates the behavior of p53 in 
response to DNA damage (Sykes et al. 2006). It suggests that hMOF has a role in 
transcriptional regulation, cell proliferation, differentiation and the DNA repair 
response (Smith et al. 2005; Taipale et al. 2005). Knowledge that NSLs are associated 
with hMOF in mammalian cells brings new directions to the study of the NLS 
complex in mammalian system, as well as hMOF itself. It is possible that NSLs are 
also binding genes in mammalian genome and regulate their transcription together 
with hMOF.  
 
In summary, the work described in this thesis defines a novel MOF containing NSL 
complex. This complex consists of a number of evolutionary conserved proteins. Its 
members colocalize on Drosophila polytene chromosomes. ChIP analysis reveals that 
the complex binds to promoters of MOF target genes, and this binding is functional, 
as it depletion of the complex members by RNAi mediated knock down leads to a 
decrease in the expression of X chromosomal and autosomal target genes. Thus, the 
NSL complex is a novel gene expression regulator, which, in Drosophila, provokes 
general transcriptional upregulation of a large number of genes. 
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5. MATERIALS AND METHODS 
 
 
5.1. Biochemical methods 
 
5.1.1. MCRS2 antibodies production 
 
Polyclonal antibodies against MCRS2 protein were raised in rats and rabbits. For this 
purpose, N-terminally GST tagged MCRS2 (1-319 aa) protein was expressed in BL21 
Rosetta (EMD Biosciences) using the pET41a vector system (EMD Biosciences). The 
protein formed inclusion bodies, which were collected and solubilized in 7 M 
guanidine HCl, 20 mM tris, pH 8.0, 10 mM DTT; unfolded in 7M urea, 20 mM 
sodium acetate pH 5.2, 0.2 M NaCl, 1 mM EDTA, 0.2 mM PMSF, 0.2 mM β-
mercaptoethanol, 1 mM DTT; and refolded back by dialysis against urea free buffer: 
50 mM Tris HCk pH 7.5, 150 mM NaCl, 1% Triton, 0.2 mM PMSF, 1 mM DTT. The 
protein was affinity purified on glutathione agarose. This material was then 
formulated with Titre-Max (Sigma) adjuvant and used to immunize 3 rats and 2 
rabbits at three week intervals for a series of six injections. 
 
Table 1. Usage of αMCRS2 antibodies in different applications. 
Animal Bleed Western IF IP (µl) ChIP 
Rat1 final 1:1000 1:200* 4 - 
Rat2 final 1:1000 - 4 - 
Rat3 final 1:1000* - 4* - 
Rabbit CDA final 1:1000 1:200* - 4* 
Rabbit CCH final 1:1000 1:200 - 4 
 
IF – immunofluorescence; 
IP – immunoprecipitation;  
ChIP – chromatin immunoprecipitation; 
* - best antibody to use for a given purpose. 
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5.1.2. Coimmunoprecipitation (CoIP)  
 
For coimmunoprecipitation experiments (Fig. 5 in the Results part), nuclear extract 
(25 mg/ml) from wild-type Drosophila embryos was used. The protocol for the 
experiment is as follows. 
 
1. Mix 100 µl extract with 600µl IP150 buffer for pre-cleaning with protein G beads 
(Sigma) for 30min at 4°C to remove unspecific resin-binding proteins.  
2. Mix the supernatant with 4 µl of the respective antibody serum or preimmune 
serum for 1 hour, rotating at 4ºC.  
3. Wash 4 times with 700 µl IP150-buffer each wash. 
4. Resuspend the beads in 50 µl of 4xSDS-loading buffer, keep at 95°C for 5min. 
5. Use 40µl of the supernatant on a SDS-PAGE for separation and subsequent western 
blot analysis with the corresponding antibodies. 
 
IP150 buffer  
HEMG150 (25 mM Hepes, 150 mM KCl, 0.2 mM EDTA, 12.5 mM MgCl2, 10% 
(vol/vol) glycerol) 
0.5% Tween-20  
0.2 mg/ml BSA 
0.2 mM PMSF 
0.5 mM DTT 
complete protease inhibitor (Roche). 
 
 
5.1.3. Western blot 
 
SDS-PAGE gel, transfer  
1. Run the gel with constant current or voltage (usual running time under 50 mA 
constant is about 1.5-2.5 hrs). 
2. Transfer for 1.5 hrs at 120 constant voltage with a ice block, stirring. Bigger 
proteins might take longer to transfer.  
3. Immerse membrane in blocking buffer for one hour or overnight, 4ºC. 
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Reagents for gel 
30% bis/acrylamide mix (i.e., 29.2% acrylamide and 0.8% N,N’-methylene-bis-
acrylamide) 
1.5 M Tris, pH 8.8 
1.0 M Tris, pH 6.8 
10% sodium dodecyl sulfate (SDS) 
10% ammonium pesrsulfate (APS)  
TEMED (N,N,N’,N’-tetramethylethylenediamine) 
 
5X running buffer:  
30.28 g Tris (FW 121.1) 
144.13 g glycine 
10 g SDS (or 10 ml 10% SDS) 
ddH2O to 2 L 
 
4X Protein Loading Buffer 
10 ml 1 M Tris pH 6.8; 
20 ml 20% SDS; 
20 ml glycerol; 
0.2 g bromophenol blue; 
1.234 g dithiothreitol (DTT; FW 154.2); 
5ml beta-mercaptoethanol. 
Store in 0.5 ml aliquots at -20°C for 6 months. 
 
Incubation with primary and secondary antibodies 
 
1. Incubate membrane with the primary antibody in blocking buffer for at least an 
hour at room temperature or overnight at 4ºC.  
2. Wash three times 5 min each with washing buffer (PBS containing 0.1% Tween20). 
3. Incubate the membrane with HRP-coupled secondary antibody at a dilution of 
1:20.000 for 45-60 min at room temperature.  
4. Wash three times 5 min each with washing buffer (PBS containing 0.1% Tween20). 
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5. Treat the membrane with ECL solutions (Amersham) and expose to X-ray film. 
 
 
5.1.4. Coomassie staining protocol 
 
The gel must be fixed prior to staining by a non-modifying, precipitation procedure 
such as the ethanol (or methanol)-acetic acid method. If the protein is not fixed in the 
gel as a separate step from the staining, the protein will be washed away and results 
will be compromised. 
 
1. Soak the gel in the gel-fixing solution for 1hr. The purpose of this step is to 
washing the SDS-containing gel buffers out of the gel.  
2. Cover the gel with the gel-washing solution, and continue to fix the proteins in the 
gel by incubating overnight at room temperature with gentle agitation. The gel should 
be covered during this process to avoid contamination and to prevent the evaporation 
of the solution.  
3. Cover the gel with the Coomassie stain. Stain the gel at room temperature for 3 to 4 
hr with gentle agitation. 
4. Cover the gel with the destain solution and allow the gel to destain with gentle 
agitation. Change the destain solution several times. Continue the destaining until the 
protein bands are seen without background staining of the gel. 
5. Equilibrate the gel in the storage solution for at least 1 hr. The gel should return to 
its original dimensions during this process. 
6. Store the gel in the storage solution as needed. It might be convenient to carefully 
transfer the gel to a heat-sealable bag for longer-term storage.   
 
Reagents 
Gel-fixing solution: Add 500 ml of USP-grade 95% (v/v) ethanol to 300 ml of water. 
Add 100 ml of acetic acid and adjust the total volume to 1000 ml with water. The 
final concentrations are 50% (v/v) ethanol in water with 10% (v/v) acetic acid. 
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Gel-washing solution: Add 500 ml of methanol to 300 ml of water. Add 100ml of 
acetic acid and adjust the total volume to 1000 ml with water. The final 
concentrations are 50% (v/v) methanol in water with 10% (v/v) acetic acid.   
 
Stain: Dissolve 0.4 g of Coomassie blue R350 in 200 ml of 40% (v/v) methanol in 
water with stirring as needed. Filter the solution to remove any insoluble material. 
Add 200 ml of 20% (v/v) acetic acid in water. The final concentration is 0.1% (w/v) 
Coomassie blue R350, 20% (v/v) methanol, and 10% (v/v) acetic acid. 
 
Destain:  Add 500 ml of HPLC- grade methanol to 300 ml of water. Add 100 ml of 
acetic acid and, after mixing, adjust the total volume to 1000 ml with water. The final 
concentrations are 50% (v/v) methanol in water with 10% (v/v) acetic acid.   
 
Storage solution: Add 25 ml of acetic acid to 400 ml of water. After mixing, adjust the 
final volume to 500 ml with water. The final concentration of acetic acid is 5% (v/v). 
 
 
5.1.5. Silver staining 
 
Gel-separated proteins are most commonly detected and quantitated by dye binding, 
utilizing the property of some dyes to bind to proteins non-specifically, making the 
proteins optically detectable and quantifiable. One of the most commonly used 
procedures is silver staining. 
 
Protocol of silver staining: 
 
1. Fix gel with destaining solution (45 methanol : 5 acetic acid : 45 water) on a 
shaking table for 20-30 mins. 
2. Rinse with water (20-60 mins, or overnight). Change water several times to remove 
acid completely and to avoid background. 
3. Sensitize gel for 3 mins with 0.02% sodium thiosulfate (prepare fresh: 0.1 g sodium 
thiosulfate in 500 ml water). 
4. Discard solution and rinse the gel with two changes of water, 1 min each.  
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5. Incubate gel in chilled 0.1% silvernitrate, (prepare fresh: 0.2 g silvernitrate in 200 
ml water) in the cold room f0r 20-40 mins without shaking, covered with alufoil. 
6. Discard/collect solution and rinse the gel with two changes of water, 1 min each.  
7. Develop the gel with 0.04% formaldehyde, 2.5% natrium carbonate (prepare fresh: 
12.5 g natrium carbonate, 150 µl 37%  formaldehyde, 500 ml water). Replace 
developing solution when it turns yellow. 
8. Quench developing solution when sufficient staining is obtained by discarding the 
solution and adding 1% acetic acid. 
9. Store silver stained gel at cold, or dry. 
 
 
5.1.6. Destaining silver gels 
 
Silver particles bind to the proteins and thus inhibit their hydrolysis. All silver stained 
gel bands cut out for the purpose of in-gel digestion should be destained. It is done 
prior to performing the in-gel digest, but after excision of the bands from the gel. 
 
1. Add 5 ml of 50% sodium thiosulfate and 7.5% potasium hexacyanoferrate per 150 
ml water.  
2. Use table shaker and incubate gel until no band is visible anymore.  
3. Rinse well with water, of possible, overnight. Change water several times.  
 
 
5.1.7 Flamingo staining  
 
Since not all proteins can be visualized by silver staining, other staining reagents can 
be used. One of them is Flamingo staining (BioRad). It is a novel dye that was 
developed from a class of dyes that are minimally fluorescent at low pH in the 
absence of protein, but acquire strong fluorescence in the presence of denatured 
protein. Flamingo staining is fully compatible with peptide mass fingerprinting by 
MALDI-MS. 
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Protocol of the Flamingo staining: 
 
1. Fix the gel o/n with 40% ethanol and 10% acetic acid 
2. Incubated in 1:10 diluted Flamingo staining (BioRad) solution for 3 to 5 hours. 
3. Incubate for 10min in a 0.1% Tween-20 solution. 
4. Scan on a PharosFX scanner (BioRad). 
 
 
5.1.8. SL-2 nuclear extracts 
 
Nuclear extract from Drosophila SL-2 cells was used for TAP purification of 
MCRS2. 
 
1. Harvest 0.3x109 cells. 
2. Pool cells, in falcon tubes and pellet by centrifugation 2000rpm, 10 min, at cold. 
3. Rinse cells, in cold PBS (5-10 ml), respin 2000 rpm for 10 min. 
4. Dounce 50 times on ice using the 1.5 ml pestle (type B). 
5. Centrifuge 10 min at 4500 rpm (SS34 or eppendorf centrifuge). 
6. Discard the supernatant. 
7. Wash pellet in 5 ml of buffer B (in corex 15 ml tubes), spin at 4500 rpm for 10 min. 
8. Resuspend in 1 ml of buffer B. 
9. Create a sucrose gradient layer by carefully laying the resuspended nuclei on 1 ml 
of better B+0.8 M sucrose in corex tubes. 
10. Spin in HB4 swing out rotor 10 min, 4000 rpm. 
11. Resuspend the nuclei pellet in 800µl of buffer B 150 (i.e. 150 mM KCl). 
12. Precipitate with 4 M ammonium sulphate (pH8.0), 82µl/ml of resuspension, rotate 
for 1 hour at cold. 
13. Ultracentrifuge 1 hour using Ti55, 16200 rpm or SW40, 26000 rpm. 
14. Take the supernatant and precipitate with 1 volume of ammonium sulphate 
(pH8.0) for 30 min, at cold. 
15. Spin in corex tubes or eppendorf, 12000 rpm, 30 min. 
16. Resuspend pellet in 40 µl of buffer C. 
 
Buffer B: 15 mM Hepes, pH 7.6; x mM KCl; 5 mM MgCl2, 0.1 mM EDTA; 0.5 mM 
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EGTA; 1 mM PMSF. B10=10 mM KCl, B150=150 mM KCl. 
 
Buffer C: 25 mM Hepes, pH 7.6; 50 mM NaCl; 5 mM MgCl2, 0.1 mM EDTA; 1 mM 
DTT; 1 mM PMSF, PI cocktail. 
 
 
5.1.9. Nuclear Drosophila embryos extract 
 
Nuclear extract from Drosophila embryo (0–12 hr collections) was used for 
coimmunoprecipitation experiments. 
 
1. Suspend embryos in 1 ml NU-I buffer. 
2. Homogenize in a 60 ml glass homogenizer with a motor-driven Teflon pestle (up to 
30 g at the time). One slow stroke at 2000 rpm followed by 5 strokes at 1500 rpm. 
3. Pass homogenate through a single layer of miracloth (Calbiochem) supported by a 
funnel over a GSA sentrifugation beaker. Use a new piece of miracloth for every 30 g 
embryos. Wash with 2 ml NU-I buffer per g embryos. Directly add to the beaker 
further 3 ml NU-I buffer per g embryos (total 6 ml of NU-I buffer per g embryo for 
the spin).  
4. Spin in GSA rotor (HB4 for smaller preps) for 15 mins at 8 K. 
5. Pour off cytoplasm, watch the nuclei pellet. Wipe side of the tubes with tissue to 
remove lipid.  
6. Resuspend pellet in 3 ml of NU-I buffer per g embryos, leaving behind the much 
tighter yellow yolk pellet (use dounce with a loose pestle to fully suspend). This step 
is optional. 
7. Spin again 15 mins at 8 K in a fresh beaker.  
8. Pour off the supernatant, wipe sides again, if necessary.  
9. Nuclei extraction: resuspend nuclei (again avoid yolk pellet) in 1 ml NU-II buffer 
per g embryo using a dounce with loose pestle. Measure the volume of the 
resuspended nuclei. 
10. Place into ultracentrifuge tube(s) and add 1/10 volume of 4 M ammonium sulfate 
to tubes and mix vigorously. The solution will become very viscous.  
12. Rotate the tubes in the coldroom for about 20 mins. 
13. Spin in a cooled untracentrifuge for 1 hr: Ti60 or Ti70 rotor at 35 krpm. 
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14. Remove supernatant with a 10 ml pipet by plunging the pipet tip well below the 
upper lipid layer and removing steadily. Leave behind the bulk of the lipid which 
interferes with subsequent ammonium sulfate precipitation.  
15. Measure volume of supernatant and place into a beaker on ice.  
16. Add to the supernatant 0.3 g per ml of finely ground ammonium sulfate in small 
aliquots over a 5 min period while stirring. Leave stirring for further 10 mins. 
17. Spin in precooled Sorvall at 15 krpm for 30 min (SS34 rotor or equivalent) 
18. Pour off the supernatant, drain well and dry the sides of the tub with kimwipe 
wrapped around a spatula.  
19. Resuspend pellet by adding 10 µl of HEMG40 per g embryo, then mixing into a 
paste with a pipet tip. Add 180 µl HEMG40 per g embryo and resuspend fully by 
pipetting up and down through a 5 ml pipet. Dialyse against 3x1 liter of HEMG40 
until the conductivity is equal to HEMG 100 (HEMG + 100 mM KCl).  
20. Spin out the precipitated protein for 5 min in an eppendorf centrifuge at 10 krpm 
in an HB4 (SS34) rotor. 
21. Snapfreeze supernatant in liquid nitrogen and store at -800C. Expect 4-5 mg 
nuclear protein per g of dechorionated embryo. Protein concentrations in Bradford 
assay are usually between 15-20 mg/ml. 
 
NU-I buffer: 15 mM Hepes-KOH, pH 7.6; 10 mM KCl; 5 mM MgCl2; 0.1 mM 
EDTA, pH 8.0; 0.5 mM EGTA; pH8.0; 350 mM sucrose. 
 
NU-II buffer: 15 mM Hepes-KOH, pH 7.6; 110 mM KCl; 5 mM MgCl2; 0.1 mM 
EDTA, pH 8.0. 
 
HEMGx: 25 mM Hepes-KOH, pH 7.6; x mM KCL; 12.5 mM MgCl2; 0.1 mM EDTA, 
pH 8.0; 10% glycerol. HEMG 40 = HEMG + 40 mM KCl 
 
 
5.1.10. TAP-tagging of the MCRS2 protein 
 
The full-length open reading frame of MCRS2 protein was subcloned into the 
multiple-cloning site of the pBSactshort-N-TAP vector (a gift from Elisa Izzaurralde). 
This pBluescript-derived vector has an N-terminal TAP tag that can be fused to the 
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protein of interest. Expression of a tagged protein is driven from a shortened Actin5C-
promoter with efficient termination of transcription conferred by a 3’ BgH1 
terminator sequence. The Actin5C-promoter drives low-level expression of TAP 
tagged MCRS2. This results in complex formation with TAP-tagged MCRS2 under 
conditions similar to those of endogenous MCRS2 expression, to preclude forcing the 
formation of aberrant complexes through over-expressing MCRS2. The MCRS2 
coding sequence was subcloned from pFastBac-FlagCG1135 by digestion with EcoRI 
(5’) and SpeI (3’). Both ends were blunted with Klenow polymerase (NEB). The 
acceptor vector, pBSactshort-N-TAP, was prepared by restriction digest with BamHI, 
followed by blunting. Analytical digests were performed with EcoRI and BamHI to 
confirm the presence and orientation of the insert. The resulting construct was named 
pBSactshort-N-TAP-MCRS2. 
 
 
5.1.11. Generation of stable Drosophila SL2 cell line 
 
A stable Drosophila TAP-MCRS2 producing SL2 cell line was established by 
cotransfecting the pBSactshort-N-TAP-MCRS2 expression plasmid and the pUC-
NEO resistance vector. Transfection was facilitated by Effectene (Qiagen), used 
according to the manufacturer’s instructions. Transfection with only the expression 
vector was performed in parallel. Following transfection, cells were incubated for 24 
hours, after which the medium was exchanged. Selection with geneticin (G418, 
Invitrogen) was initiated 48 hours after transfection, with a range of antibiotic 
concentrations, between 0.8 and 1.2 mg/ml of geneticin, used. Selection was 
monitored by the complete death of mock transfected cells and colony formation of 
stably expressing cells in cells transfected with the selection vector. Heterogeneous 
populations of transfected cells were then used to derive cell lines. 
 
 
5.1.12. Tandem affinity purification (TAP) 
 
The TAP purification protocol (Rigaut, 1999) was adapted for Drosophila embryo 
nuclear extracts (Sascha Mendjan). 
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1. Spin down extracts immediately after thawing at max speed for 15min. 
2. Dilute nuclear extract is in IgGBB150 to about 5mg/ml protein concentration, and 
spun down at rpm max for 15min. 
3. IgG beads (Roche) should be tested by boiling in 1xSDS LB for IgG release. If they 
release IgG (fat coomasie band at 50kDa) crosslink the beads with dimethyl-
pimelidate. Beads are equilibrated in IgGBB150 before binding.  
4. Diluted extract is bound to IgG beads at 4°C for 1h-1h30min max.  
5. Save supernatant (for binding control) and wash beads 3x with IgGBB150 and 3x 
with IgGBB200 (identical to IgGBB150 but with 200 mM KCl). The last 2 washes 
should be 5-10’ each and at room temperature RT.  
6. Resuspend beads in TEV cleavage buffer CB150. Wash once in CB150 without 
TEV at RT, before you add the CB150+TEV. 
7. Cleave at 18°C for 2h rotating slowly in an appropriate tube (2/3-3/4 full). 
8. Take off the supernatant, spin it down at max speed for 5’ 4°C, and save the beads 
(freeze). Add 3µl of 1M CaCl2 per 1ml of cleavage supernatant. 
9. Dilute cleavage supernatant in calmodulin binding buffer CalBB150 in a 1:3 ratio. 
Equilibrate calmodulin beads in CalBB150 before binding. Bind for 2h at 4°C. 
10. Spin down beads and save the supernatant (binding control). Wash beads (each 
wash 5-10min) 2xCalBB150 at 4°C, 2xCal150 at RT, and 2xCalBB200 at RT. Final 
wash is in CalBB150 (with Tris pH7.6 instead of Hepes: this final change to the Tris 
buffer system is because of the subsequent PAGE run that is also Tris based). 
 
11. To avoid presence of non-specifically bound proteins, as well as to result in 
purifying a complex for further biochemical analysis, elute proteins with CalEl150 for 
15’-30’ at 4°C rotating/shaking. If the non-specific binding is low, proteins can be 
directly eluted by boiling in 1xSDS (with beta-mercaptoethanol, no DTT). 
 
IgGBB150 buffer: (25mM Hepes pH7.6, 150mM KCl, 5mM MgCl2, 0.5 mM EDTA, 
20% glycerol and 0.5mM DTT, 0.2%Tween20, 0.4mM PMSF, Complete protease 
inhibitor (Roche). 
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IgGEl150 buffer: (20mM Tris pH7.6, 150mM KCl, 5mM MgCl2, 0.5 mM EDTA, 
20% glycerol and 0.4mM PMSF, 200ng/ml FLAG peptide, 1/100 elution volume 
RNAsin (Promega) if RNA is co-purified. 
 
CB150 buffer: (20mM Hepes pH 7.6, 150mM KCl, 0.5mM EDTA and 0.5mM DTT, 
0.1% Tween20, 0.4mM PMSF, 10microg/ml TEV and 1/100 volume of RNasin 
(Promega) if RNA should be co-purified. 
 
CalBB150 buffer: (20mM Hepes/10mMTris pH7.6, 150mM KCl, 2mM Mg-Acetate, 
1mM Imidazol, 3mM CaCl2, 20% glycerol and 10mM beta-mercaptoethanol, 
0.2%Tween20, 0.4mM PMSF, Complete protease inhibitor)  
 
CalEl150 buffer: (10mM Tris pH7.6, 150mM KCl, 2mM Mg-Acetate, 1mM Imidazol, 
3mM EGTA, 20% glycerol and 10mM beta-mercaptoethanol, 0.4mM PMSF, 
RNasin). 
 
 
5.1.13. Identification of purified proteins by mass spectrometry 
 
Both excision of specific to TAP-tagged MCRS2 purification bands (performed by 
Sven Fraterman, EMBL-Heidelberg) and analysis of total complex elutions have been 
done (Adrian Cohen, NCLMS, Netherlands).  
 
 
5.1.14. Chromatin from Drosophila SL-2 cells 
 
1. Fix 40 ml almost dense cell culture (4x106 cells / ml) with 4 ml of fixation mix (7.1 
ml Paro fix solution (50mM HEPES, 1mM EDTA, 0.5mM EGTA, 100mM NaCl) + 
2.9 ml FA (37% stock)). 
2. Incubate 8 mins at RT. 
3. Stop with 2 ml 2,5M glycine, 10 min on ice, spin 5 mins cold. 
4. Wash pellet in 40 ml Paro Pinse 1 (10mM tris pH8, 10mM EDTA, 0,5mM EGTA, 
0,25% triton X 100), incubate 5 mins on ice, spin. 
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5. Wash pellet in 40 ml Paro Pinse 2 (10mM tris pH8, 1mM EDTA, 0,5mMEGTA, 
0,2mM NaCla), incubate 5 mins on ice, spin. 
6. Resuspend in Ripa buffer in the appropriate for sonication volume (400 µl). 
7. Sonicate 3 times 15sec. 
8. Spin at high speed for 10 mins, cold. 
9. Use supernatant (can store at -80). Take 25-100 ug/ul of the chromatin for an IP. 
 
 
5.1.15. Chromatin from Drosophila third instar larvae salivary glands 
 
Chromatin from Drosophila embryos was prepared according the protocol developed 
by Orlando et al (Orlando et al, 1997). 
 
1. Dissect male III instar larvae salivary glands (10 pairs per ChIP) 2. Fix for 15 min 
at room temperature in 1mL of fixing solution (50mM HEPES pH 7.6, 100mM NaCl, 
0.1mM EDTA pH8, 0.5mM EGTA pH8, 2% formaldehyde), on a wheel.  
3. Centrifuged at 2000rpm for 1min. 
4. Wash once in PBS-0,01%Triton X100-0,125M glycine. 
5. Wash  for 10 min in 1mL of  buffer A (0,25% Triton X100, 10mM EDTA pH8, 
0.5mM EGTA pH8, 10mM Tris pH8). 
6. Wash for 10 minutes in Buffer B (200mM NaCl, 10mM Tris pH8, 10mM EDTA 
pH8, 0,5mM EGTA pH8). Can freeze in N2 and keep for weeks. 
7. Resuspend the glands in 500 ml of sonication buffer (10mM Tris pH8, 1mM EDTA 
pH8, 0.5mM EGTA pH8). Transfer in the specific tubes for sonication. 
8. Sonicate 3 times 10s using a Branson Sonifier 250, power 2, with a microtip. 
9. Sonicate 8 min (8 times pulse 30s, paused for 30s, high) using a Bioruptor (Cosmo 
Bio). 
10. Adjust the samples to 0.5% sarcosyl (add 50µl for 1mL of extract). 
11. Incubate on a wheel for 10 min at room temperature. 
12. Centrifuged at 14000rpm for 10 min. 
13. Dialyze at 4°C ON against 5% glycerol, 10mM Tris pH8, 1mM EDTA pH8, 
0.5mM EGTA pH8.  
14. Perform chromatin immunoprecipitation using 500µl of chromatin, according to 
Orlando et al, 1997. 
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5.1.16. Chromatin immunoprecipitaion, ChIP  
(adapted from J. Muller lab) 
 
1. Thaw an aliquot of chromatin and use the appropriate amount for the ChIP  
2. Adjust the volume to 500µl with ice-cold dialysis buffer (4% glycerol, 10mM 
TrisHCL pH 8, 1mM EDTA, 0.5mM EGTA) 
3. Adjust to RIPA conditions by addition of TritonX100, sodium deoxycholate, SDS 
and NaCl. 
4. Add 40µl of the 50% (v/v) ProteinA Sepharose (PAS) suspension (100mg Protein 
A Sepharose CL4B, Sigma, equilibrated in 1ml RIPA buffer for 30-60min; this will 
swell the beads with RIPA up to 500 µl volume. Spin down 30 sec and take up to 1 ml 
new RIPA buffer). RIPA Buffer: 140mM NaCl / 10mM Tris-HCl pH8,0 / 1mM 
EDTA / 1% TritonX100 / 0,1% SDS / 0,1% sodium deoxycholate, 1mM PMSF (on 
ice); add PMSF immediately before use). 
5. Incubate the chromatin with the PAS for 1h at 4°C with gentle mixing, then spin 
down for 30sec at max speed. This acts as a preclearing step to reduce non-specific 
binding to protein A sepharose.  
6. Remove the chromatin to a new tube and add 2-5µg of the appropriate antibody and 
control (preimmune serum). 
7. Incubate overnight at 4°C with gentle mixing. Purify immunocomplexes by adding 
40µl 50% PAS suspension (100mg Protein A Sepharose CL4B, Sigma, equilibrated in 
1ml RIPA buffer for 30-60min. Spin down and take up in new 1ml RIPA buffer) and 
incubate for 3h at 4°C with gentle mixing. Use filtered tips during the ChIP. 
8. Wash complexes 5 times with 1ml RIPA for 10 min each, once in LiCl buffer 
(250mM LiCl / 10mM Tris-HCl pH 8,0 / 1mM EDTA / 0,5% NP-40 / 0,5% sodium 
deoxycholate; prepare it well in advance so that NP-40 has time to get dissolved 
properly) and twice in TE (10mM Tris-HCl pH 8,0 / 1mM EDTA). Carry out all steps 
at 4°C using 1ml wash buffer and always spin at max speed for 30 sec to pellet PAS 
before removing the supernatant. 
9. Add DNase-free RNase A (in approx. 50 µl TE buffer) to the PAS complexes up to 
50µg RNase A/ml, and incubate for 30min at 37°C. 
10. Adjust the samples to 0,5% SDS, 0,5mg/ml Proteinase K (premix SDS and 
Proteinase K in at least 40 µl buffer TE) and incubate overnight at 37°C, followed by 
6h at 65°C to reverse the cross-link. 
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11. Phenol/chloroform extract the sample with adding 1 Vol phenol, 20 sec vortex, 1 
Vol chloroform, 20 sec vortex, 2 min max speed centrifugation. Take the upper phase 
and add 2 Vol chloroform, 20sec vortex, 2min centrifuge. OR, if you use Phase Lock 
Gel Heavy® tubes, spin down gel in tubes (maximum speed 30 seconds), put liquid 
from  Proteinase K into tube, add one volume V of phenol (take it from the lower 
phase), stir vigorously (around two minutes), add one volume V of chloroform, and 
stir vigorously again. Centrifuge at 16000g (max speed in microfuge) 5 min. Add then 
two volumes V of chloroform, stir vigorously, and again spin down at top speed five 
min. Take phase that is on top of gel. 
Precipitate the upper phase by adding 1µl 20mg/ml glycogen (as carrier), 1/10 volume 
(V', the new volume you got after extraction) 3M NaOAc pH 5.2, add 2,5 V' ethanol. 
Put at –80°C for 30min before centrifuging at 4°C for 20min at full speed. Wash 
pellet in 1ml 70% ethanol, turn tube, centrifuge at 4ºC 3 min max speed, discard 
supernatant, air-dry and resuspend in 500µl H2O. Store at –20°C. 
 
As an option to step 11, one can use MinElute columns (Quagen) for to purify DNA 
after RNase A, proteinase K treatments and reverse crosslinking. 
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Table 5. Primers used for qPCR in chromatin immunoprecipitation. 
Name Forward primer (5’-3’) Reverse primer (5’-3’) 
Position 
relative 
to a TSS 
CG4406-5’ ACAGCTGGCGAGGATCAG TCGATACTCGAGGCGTTG +60 
CG4406-mid CCAACTCCTGGCTGGTTATC GGCAGCAATGTGCTCATCTA +570 
CG4406-3’ TTGAAGGGCTTTTTGGTCAC TTGAAGGGCTTTTTGGTCAC +1280 
CG6506-5’ AGGGCCCGATAAGTAAACAA GCCCCAGTGCTCTGTTTG +60 
CG6506-mid CAGCTGGTCCCACTGGAG ATTCCTGGCCAGCACCTT +850 
CG6506-3’ GCAATGGAAATGGCAATG TGAAGTTATCCCCGCAATTT +1270 
Rb-5’ AAAAATCATCAGCACGGAAA ATTGCTGGCCGAGTTCTG +300 
Rb-mid TGCCCGCCAAGTATTTCT CGCTGGCATGTTCAGGTA +2340 
Rb-3’ CTCCAAAAGCCTCGTGCT CCATGGATCCAATGACCA +3840 
dSPT6-5’ CGCTCACAAACTCTTCGTTT ACACCTACCTCCGATTCCTC +110 
dSPT6-mid CGAGGCGATAGTTGTACCAG CATAGGGACTGCTGTTGGAC +2663 
dSPT6-3’ TACAATGTCACTGGGACGTG CGAGGACATACCCCGATTAT +6454 
Sec5-5’ GCCAAGATTTCACCACTGAC ATGCGGAAAAACTGATCAAA -60 
Sec5-mid ACTCCCATTGGCGATAAACT TGGTGTGCTGATCAAATGTC +1350 
Sec5-3’ TGAGACTGCCAAGTGAGTGA CAGCGCTTCCATGAAGTAGT +2780 
CG9536-5’ AGACCACCCGGTTCCAGT CACCGATCGCTTCTCCTG -30 
CG9536-mid CGGAGAGCTTCACGTTCG CCCGCAAACAGCAATTGTA +2780 
CG9536-3’ CCAGCTGCCCATCACAAC CACCTTGACCCGGAACAT +2040 
OdsH-5’ CAGTGTCAGCAAAAGCATTG GATGAACCATGGGGATGTT +10 
OdsH-mid TCTGGGGCAGAATGATTGTA CGCTATACGACCCTCCATTA +20770 
OdsH-3’ GTTGAACCGGAGTACGTGA GAGGGTCTTATTCTGCATCG +22750 
Gprk2-5’ CTTGTTTTGCGAGCCTTTTC CAGAACACACACACGCACAC +220 
Gprk2-mid GTCGCTTCTTGGATGTCGAG CTGCGAGTTGTTGCTGTTGT +48540 
Gprk2-3’ TTGCCCATTGGGTATGCT TTTGCAAAAGCGCACTCC +54540 
roX1-prom GTGTATTTTGCAATTGGA CGCATTCATGCAGTTCCC +48540 
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5.2. Cytological methods 
 
5.2.1. Immunofluorescence on SL-2 cells 
 
SL-2 cells are grown on cover slips at a density of 7 x106 cells ml-1. After 1 wash in 
PBS, cells are fixed in 3.7% Formaldehyde in PBS–10 min RT and blocked in 
solution 1 (5% BSA, 0.1%Tween, 0.1% Triton in 4X SSC) for 1 hour at RT or o/n at 
4°. Cells are incubated with primary antibody diluted (anti-MSL-1, anti-MSL-2, anti-
MSL-3 and anti-MOF: 1/500; anti-MLE: 1/250) in solution 1 for 1 hour at RT. After 
washing 3X 10 min in 0.1% Tween, 0.1% Triton, 4X SSC, cells were incubated in 
secondary antibody and Hoechst, diluted in solution 1, for 1 hour RT. After 3X 10 
min washes in 0.1% Tween, 0.1% Triton, 4X SSC coverslips were mounted on a slide 
with a drop of Fluoromont-G. 
 
5.2.2. Immunostaining of polytene chromosome. 
 
Preparation of 3rd instar larvae 
1. Add a large drop of live baker's yeast on top of the dried medium. 
2. Let the flies lay eggs just to the point where larvae will hatch under uncrowded 
conditions (<100 larvae/bottle). 
3. Grow larvae at 180C. 
4. For salivary gland preparations use 3rd instar larvae that are still crawling and have 
not started to pupate, yet. 
 
Chromosome squashes 
1. Dissect two pairs of salivary glands in PBS. 
2. Fix glands (3.7% Paraformaldehyde in H20 for 10 min) in poly-lysine treated slide. 
3. Cover glands with a SIGMA-cote treated cover slip. 
4. Tap the coverslip with a pencil until cells are broken up. Hold the coverslip and 
spread extensively the chromosomes. Remove excess fixative by pressing slides 
(coverslip down) onto blotting paper. 
5. After freezing slides in liquid nitrogen flick off coverslip with a razorblade. 
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6. Wash slides two times for 15 min. in PBS slowly shaking the rack. 
7. Proceed with the immunostaining or keep the slides (up to one week) in 100% 
Methanol or Ethanol (for EGFP staining). 
 
Immunostaining 
1. Stored slides are washed 2-x 15 min. in PBS. Block for 1 hour in blocking solution 
at room temperature. 
2. Add 20 µl to each slide of affinity purified primary antibodies (i.e. rabbit 
polyclonal antibodies; dilutions 1:50 to 1:500 in blocking solution need to be adjusted 
for each individual primary antibody). Cover with coverslip and incubate for 1h at 
room temperature in a humid chamber. 
3. Rinse in PBS 
4. Wash 15 min in PBS, 300mM NaCl, 0.2% NP40, 0.2% Tween20-80; 
15 min in PBS, 400mM NaCl, 0.2% NP40, 0.2% Tween20-80; 
(If background problems persist, NaCl conc. can be raised to 500mM) 
5. Shake rack thoroughly during washing procedure. 
6. Rinse in PBS 
7. Add 20 µl diluted secondary antibody (fluorescent labeled like Cy3- Anti-Rabbit 
IgG (Fc) (Dianova), or Anti-Rabbit IgG (Fc) HRP Conjugate, Promega Kat. Nr.: 
W4011, 1:100 dilution) + Hoechst (1:3000 dilution) in blocking solution. Cover with 
coverslip and incubate for 40 min. at rt. in humid chamber. 
8. Rinse in PBS. 
9. Wash 15 min in PBS, 300mM NaCl, 0.2% NP40, 0.2% Tween20-80; 
3-15 min in PBS, 400mM NaCl, 0.2% NP40, 0.2% Tween20-80; 
10. Shake rack thoroughly during washing procedure. 
Rinse in PBS. 
11. Mount the chromosomes in 10µl Fluoromont G. 
 
 
5.2.3. Confocal microscopy 
 
For cells and polytene chromosomes, images were captured with an AxioCamHR 
CCD camera on a Leica SP2 FCS spectral filterless confocal microscope (Leica 
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Microsystems) using 63x PlanApochromat NA 1.32 oil immersion objective and the 
Leica Confocal Software V2.61. 
 
5.2.4 Double-stranded RNA interference  
RNA interference was performed essentially as described before (Clemens et al. 
2000) with the few modifications. S2 cells were grown at 25°C in Schneider’s 
Drosophila medium (Gibco) supplemented with 10% foetal bovine serum and a mix 
of 100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen). Gene-specific 
dsRNAs were amplified by PCR from corresponding cDNAs using T7-tailed 
oligonucleotides. Products were about 300 (for MCRS2, MBDR2 and EGFP) or 600 
(for MOF, MSL1) nucleotides long. The resulting PCR products were transcribed 
using the T7 RiboMAX Express Large Scale RNA Production System (Promega). A 
total of 6x106 S2 cells were incubated with 45µg dsRNA per 1x106 cells, additional 
45µg dsRNA were added on day 2 and harvested after 5 days. 
 
Table 6. Primers used for RNAi mediated knock down. 
Name Forward primer (5’-3’) Reverse primer (5’-3’) 
T7-MOF 
TTAATACGACTCACTATAGGGAGA 
ATGTCTGAAGCGGAGCTGGAACAG 
TTAATACGACTCACTATAGGGAGACGA 
AGTCGTCAATGTTGGAACCAC TG 
T7-MCRS2 
TTAATACGACTCACTATAGGGAGAGCG 
TCTAGAGACCAGGAAGGTGAAGCGCAGA 
TTAATACGACTCACTATAGGGAGACGC 
GAATTCCCTCCGAGTTCGACAACCAGACA 
T7-MBDR2 
TTAATACGACTCACTATAGGGAGAGGCC
GTCCTCTTCGCCATACTCGCAGATGCA 
TTAATACGACTCACTATAGGGAGA 
GCTCTCAGCGTCGTCCCATTTTGTCAGAT 
T7-MSL1 
TTAATACGACTCACTATAGGGAGA 
ATGTCTGAAGCGGAGCTGGAACAG 
TTAATACGACTCACTATAGGGAGA 
CGAAGTCGTCAATGTTGGAACCACTGCC 
T7-EGFP 
TAATACGACTCACTATAGGGAGG 
ATGGTGAGCAAGG 
TAATACGACTCACTATAGG 
GAGGATCGCGCTTCTCG 
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